rfhg_24567.1

Basic information about the TSS

---

TSS ID: rfhg_24567.1 TSS ID(Version3): hg_27531.1 hg_27532.1 hg_27533.1 hg_27534.1 Species: human Chr: chr2		Start: 27663566 End: 27663668 Strand: -
Source datasets	FANTOM5|PRJDB5282|PRJNA548673|PRJNA401781|DRA013844 |PRJNA615891|PRJNA4843412|PRJNA597322
Protocol	CAGE|C1CAGE|ReCappable-seq|RAMPAGE|oligo_capping|TIF-seq2 |SLIC_CAGE|NETCAGE|STRIPE-seq
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3102415,EH38E1982924)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000337768.10:0 ENST00000406540.5:0 ENST00000405491.5:0 ENST00000464789.2:0 AB018307:0 AF224759:0 BC045638:0 BC074000:0 AK000329:0 AF197954:0 AK304889:0 GeneID: 9913 HGNC/MGI_ID: HGNC:30632 UniProt_ID: O94864 Nearer transcript ids and distances: LF358123:-117 MA593700:-117 ENST00000404798.6:-172 AK000616:177 view more...

Gene_name: SPT7 like, STAGA complex subunit gamma Gene_symbol: SUPT7L Gene_synonyms: KIAA0764 SPT7L STAF65 STAF65gamma Gene_source: HGNC:30632

TATA-Box annotation

---

Distance to TSS:	-3
Nearest PromoterID:	NM_014860
Entrez ID:	9913
Nearest Unigene:	Hs.6232
Nearest Refseq:	NM_014860
Nearest Ensembl:	ENSG00000119760
Gene Name:	SPT7 like, STAGA complex subunit gamma
Gene Alias:	SPT7L|STAF65|STAF65(gamma)|STAF65G|SUPT7H
Gene Type:	protein-coding
CpG%:	0.058824
GC%:	0.495146
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SUPT7L p2@SUPT7L p3@SUPT7L p4@SUPT7L p5@SUPT7L p6@SUPT7L p7@SUPT7L p8@SUPT7L p9@SUPT7L p10@SUPT7L
Sample		p1@SUPT7L	p2@SUPT7L	p3@SUPT7L	p4@SUPT7L	p5@SUPT7L	p6@SUPT7L	p7@SUPT7L	p8@SUPT7L	p9@SUPT7L	p10@SUPT7L
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	40.13	3.12	2.53	2.73	1.56	0.78	0.58	0.58	0.58	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	41.27	4.45	1.62	4.05	1.42	0.40	0.20	1.01	0.81	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	37.81	4.44	1.54	2.70	2.51	0.58	0.96	1.16	0.39	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	37.84	3.74	1.25	5.61	1.25	1.04	1.66	1.25	0.62	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	34.19	5.40	1.35	5.85	2.25	0.22	0.67	1.80	0.67	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	39.15	6.20	1.55	8.53	2.71	0.97	0.97	1.36	1.36	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	57.30	6.54	3.70	3.70	1.74	1.31	1.09	0.22	0.65	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	46.51	6.54	2.18	4.60	1.21	0.48	0.48	0.73	0.73	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	43.17	5.56	1.92	5.34	1.07	1.07	1.07	0.64	0.00	1.71
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	82.89	11.59	4.64	8.69	2.32	4.06	2.32	2.32	4.64	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	70.74	10.11	4.45	9.70	2.83	2.02	0.40	0.81	2.02	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	58.14	9.76	5.69	10.98	4.07	4.07	0.41	1.22	0.81	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	36.91	6.93	0.97	2.26	0.16	0.00	1.13	0.16	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	38.04	4.81	1.35	1.20	0.15	0.15	1.95	0.00	0.45	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	39.74	5.27	1.76	2.42	0.44	0.44	1.76	0.66	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	39.23	5.28	1.26	2.01	0.50	1.01	1.51	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	33.63	8.52	1.97	1.31	0.66	0.66	1.53	0.22	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	38.39	4.64	0.84	2.53	0.42	0.42	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	42.65	3.73	1.07	1.60	0.53	0.53	0.53	0.00	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	37.46	2.86	1.05	1.50	0.30	0.60	1.20	0.00	0.45	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	33.01	4.68	1.34	1.87	0.13	0.13	0.94	0.00	0.13	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	33.14	5.87	1.38	0.69	0.17	0.69	1.90	0.00	0.35	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	32.57	4.39	0.65	1.94	0.00	0.13	1.29	0.13	0.52	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	35.67	6.79	0.24	2.91	0.00	0.49	1.46	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	36.63	5.93	2.06	2.06	0.77	0.26	1.55	0.00	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	40.83	9.50	0.95	0.63	1.27	0.00	0.63	0.00	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	42.86	7.14	0.00	3.30	0.00	0.55	0.55	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	34.66	5.89	2.12	2.59	0.24	0.24	2.83	0.00	0.71	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	38.28	5.33	1.29	2.75	0.81	0.48	1.29	0.16	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	38.36	5.43	0.90	3.44	0.18	0.18	1.27	0.36	0.18	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	39.57	5.86	0.84	2.72	0.63	0.21	1.05	0.42	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	39.27	8.60	1.95	3.32	0.98	1.17	1.95	0.00	0.59	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	40.31	6.96	1.27	1.90	0.00	0.00	1.06	0.21	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	40.58	6.27	2.31	2.97	0.49	1.15	1.65	0.99	0.33	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	43.19	6.54	2.24	3.37	0.37	0.56	1.87	0.00	0.37	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	38.71	7.47	1.72	3.07	0.57	0.57	1.72	0.19	0.19	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	43.94	5.93	1.84	3.47	0.20	0.20	1.43	0.41	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	34.05	5.44	1.61	3.43	0.40	0.81	1.01	0.40	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	48.62	6.21	1.08	2.70	0.81	0.54	2.16	0.00	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	36.01	3.84	0.48	1.68	0.48	0.48	0.48	0.24	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	29.64	4.94	1.88	2.35	0.24	0.94	0.47	0.00	0.00	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	36.01	5.56	1.32	3.07	0.88	0.00	0.88	0.00	0.15	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	31.42	5.69	1.05	3.37	0.00	0.21	0.42	0.42	0.42	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	33.74	5.59	1.75	4.20	0.17	0.35	0.87	0.17	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	33.33	6.63	1.61	2.61	0.20	0.40	1.20	0.00	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	34.43	3.26	2.09	2.09	0.23	1.16	1.63	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	35.27	4.80	0.72	2.40	0.72	0.96	0.96	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	36.66	8.05	0.89	1.79	0.00	0.60	0.89	0.00	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	39.26	4.55	1.20	3.11	0.48	0.48	1.68	0.24	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	40.84	3.24	1.21	2.63	1.01	0.81	1.62	0.20	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	29.92	3.89	2.05	1.43	0.41	0.61	1.23	0.00	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	31.35	5.11	1.33	2.45	0.89	1.11	0.44	0.67	0.44	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	32.65	1.77	1.06	1.77	0.00	0.35	0.71	0.35	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	30.82	2.65	1.33	0.33	0.33	0.33	0.66	0.00	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	40.27	1.68	1.68	3.36	0.84	3.36	0.84	0.84	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	30.31	0.92	2.30	2.30	0.92	0.92	1.84	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	32.09	2.92	1.62	1.62	0.00	0.65	0.65	0.00	0.65	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	27.62	6.10	0.32	1.61	0.32	0.00	0.64	0.32	1.28	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	23.57	3.77	3.77	3.14	0.31	0.31	0.63	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	19.74	4.94	2.12	0.71	0.00	1.41	0.71	0.00	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	24.67	4.49	0.56	3.36	0.00	1.12	0.56	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	27.86	3.18	3.18	0.00	0.00	0.80	1.59	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	32.96	2.72	1.70	1.70	1.70	0.00	1.70	0.00	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	28.92	3.57	1.30	0.97	0.97	0.32	1.30	0.00	0.32	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	31.59	3.55	0.71	2.13	0.71	1.06	0.35	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	94.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	24.86	1.95	0.49	1.46	0.49	0.98	0.49	0.00	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	26.78	2.48	2.48	0.50	0.00	0.00	0.00	0.50	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	26.27	4.22	0.94	1.41	1.88	0.00	0.47	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	28.81	2.65	0.66	1.66	0.99	0.66	1.32	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	24.75	3.09	1.55	1.24	0.31	0.31	1.24	0.00	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.35	2.45	0.61	2.14	0.92	0.31	0.61	0.31	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	30.88	4.91	1.90	3.64	0.32	1.27	1.43	0.00	0.32	0.79
Adipocyte - breast, donor2	11327-117E4	20.53	2.57	2.73	1.28	0.48	1.12	0.32	0.16	0.48	0.32
Adipocyte - omental, donor1	11473-119C6	37.53	7.38	2.16	3.56	0.51	1.53	1.53	0.25	0.76	0.25
Adipocyte - omental, donor2	11474-119C7	11.96	6.73	3.74	2.99	0.00	1.49	1.49	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	18.09	3.01	1.00	4.02	0.67	1.34	1.67	0.33	0.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	21.05	1.28	1.91	3.19	0.00	0.64	1.28	1.28	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	21.99	3.30	0.00	0.00	0.00	0.00	2.20	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.06	2.26	1.81	0.90	0.00	0.45	1.35	0.45	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	27.11	2.78	2.09	1.74	0.00	1.39	0.35	0.00	0.87	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	41.27	8.02	2.74	2.35	0.78	1.56	0.20	0.20	0.59	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	35.52	5.92	1.03	2.06	0.77	0.26	1.03	0.26	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	35.40	5.30	1.95	1.67	0.84	1.39	0.56	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	36.44	5.29	2.94	2.35	0.59	2.94	1.76	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	39.81	4.02	7.24	1.61	0.56	3.38	0.48	0.24	1.45	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	27.76	2.58	4.20	3.55	0.97	0.32	0.32	0.00	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	29.86	4.27	1.07	1.07	1.07	1.07	0.53	0.53	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	31.16	4.45	1.67	2.23	1.11	2.23	1.11	0.00	2.23	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	29.53	2.08	4.16	0.83	0.00	0.42	0.42	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	32.65	2.26	4.02	1.00	0.25	2.01	0.50	0.00	0.75	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	27.49	1.64	2.29	0.33	0.65	2.62	0.33	0.00	0.98	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	24.36	1.83	5.78	0.61	0.61	0.61	0.00	0.30	0.91	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	21.88	1.10	0.22	1.10	0.44	0.00	0.44	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	23.67	2.87	1.43	1.79	1.08	0.00	0.36	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	21.56	0.00	0.00	0.00	2.40	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	29.32	1.80	1.26	1.98	0.72	1.08	1.26	0.72	0.36	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	50.20	1.67	0.00	3.35	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	30.82	2.67	2.47	1.64	0.41	0.62	0.21	0.21	0.82	0.00
Anulus Pulposus Cell, donor1	11248-116E6	34.10	4.69	0.69	0.69	0.57	0.46	1.03	0.11	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	16.41	1.47	0.49	0.98	0.24	0.49	0.49	0.24	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	19.32	1.80	2.25	1.35	0.00	0.45	0.45	0.90	1.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	20.40	2.17	0.87	1.74	0.00	0.00	0.00	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	0.00	2.14	2.14	4.28	4.28	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.63	2.39	1.20	0.90	0.30	0.00	0.60	0.90	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	26.56	2.53	3.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	18.48	2.64	0.00	0.66	0.66	0.00	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	24.04	2.92	0.65	0.65	0.00	0.00	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	29.13	1.46	2.43	0.49	0.00	0.49	0.97	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.60	2.38	0.59	1.19	0.00	0.00	1.19	0.00	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	25.61	1.13	1.88	1.51	0.38	0.38	0.75	0.00	1.51	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	24.67	0.73	0.73	2.90	0.73	0.00	0.73	0.73	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	23.82	2.51	0.00	0.00	0.00	0.00	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.01	3.62	0.66	1.15	0.66	0.49	0.00	0.16	0.66	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	2.73	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.61	3.77	0.90	1.36	1.21	0.60	0.90	0.15	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.07	1.61	1.07	1.07	0.54	0.00	0.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	20.03	1.70	0.57	1.51	0.57	0.19	0.19	0.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	22.72	2.41	1.34	1.07	0.80	0.27	0.53	0.00	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	25.36	0.00	0.98	2.93	0.00	0.00	0.98	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	21.23	1.66	1.49	0.33	0.66	0.33	0.33	0.33	0.66	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	6.00	0.00	1.20	2.40	1.20	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	19.90	2.40	2.06	1.72	0.86	0.00	0.51	0.00	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	0.00	0.00	12.58	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	22.33	1.94	1.94	0.49	0.49	0.49	0.00	0.00	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	19.73	2.66	0.38	0.76	0.00	0.00	0.38	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	18.17	4.85	1.21	3.63	1.21	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	23.37	3.42	1.14	0.00	0.57	1.14	0.57	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	23.73	2.14	0.86	1.07	0.64	0.64	0.86	0.64	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	23.49	2.32	0.52	1.55	0.52	0.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	23.46	2.35	0.94	0.47	1.41	0.47	0.94	0.47	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	19.94	0.96	0.32	0.96	0.32	0.00	0.64	0.00	0.96	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.83	1.43	0.00	1.43	0.71	0.00	0.71	0.71	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	18.13	0.58	2.92	0.58	1.75	0.58	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	23.48	1.20	3.01	0.30	0.00	0.60	0.30	0.90	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	26.14	2.38	1.19	1.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	27.46	2.03	1.02	1.02	0.51	0.00	0.00	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.14	1.78	1.78	1.53	0.76	0.00	1.27	0.25	0.51	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	21.60	3.18	0.00	2.54	1.27	0.00	0.64	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	28.91	0.43	1.29	1.29	1.29	0.43	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	17.36	1.69	1.69	0.85	0.21	0.21	0.42	0.21	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	24.65	2.03	0.58	2.61	1.16	0.29	0.00	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	19.84	0.94	0.00	3.78	0.94	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	19.66	1.70	0.34	1.36	0.00	0.17	0.51	0.34	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	4.63	0.00	0.00	0.00	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	4.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	20.58	3.00	0.43	0.64	0.21	0.00	0.43	0.00	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	24.67	4.81	1.20	2.41	0.60	1.20	0.60	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	28.43	4.37	0.00	2.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	23.22	2.53	0.69	1.38	0.23	0.46	0.00	0.00	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	7.65	0.00	2.55	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	33.81	3.05	1.02	1.53	1.02	0.51	0.25	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	22.50	2.68	1.24	1.65	0.21	0.62	1.03	0.21	0.62	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	22.03	2.45	0.31	1.84	2.14	0.31	0.92	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	19.60	2.39	1.43	0.48	0.48	0.00	0.48	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	18.18	2.44	1.11	1.11	0.67	0.22	0.44	0.44	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	30.52	1.53	0.00	1.53	0.00	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	16.06	3.32	0.55	1.66	1.11	0.55	0.00	0.55	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	21.45	3.18	1.06	1.32	0.53	0.00	0.79	0.00	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	31.26	3.63	1.09	1.09	0.73	0.00	1.45	0.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	48.14	4.42	1.72	2.95	0.98	0.98	1.23	0.86	0.61	0.12
Astrocyte - cerebellum, donor2	11580-120F5	35.94	3.25	1.03	1.54	0.51	0.86	0.68	0.34	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	41.53	7.76	0.63	3.15	0.42	0.00	1.26	0.21	0.42	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	45.66	8.71	2.09	1.05	1.05	1.05	0.70	0.00	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	44.97	5.82	1.78	2.59	0.65	0.32	0.65	0.49	0.65	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	42.36	4.18	1.49	1.79	0.60	0.60	0.89	0.75	0.30	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	40.94	3.78	1.83	0.92	1.15	0.34	0.80	0.46	0.11	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	42.60	5.14	1.50	1.38	0.75	0.13	0.50	0.50	0.50	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	44.15	5.92	0.68	0.68	1.59	0.00	0.91	0.23	0.34	0.11
Basophils, donor1	12241-129G9	44.98	2.09	0.52	1.57	3.40	0.26	0.26	0.52	0.00	0.00
Basophils, donor2	12242-129H1	74.32	3.61	3.61	1.08	2.89	0.36	0.72	0.00	0.36	0.00
Basophils, donor3	12243-129H2	47.04	2.79	1.91	0.29	2.79	0.59	0.15	0.15	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	25.87	0.86	0.65	1.29	0.65	0.22	0.22	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	48.00	1.83	0.00	2.29	0.00	0.00	0.46	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	31.38	5.65	1.26	3.14	0.63	0.63	0.63	0.63	0.63	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	23.08	2.91	0.62	1.66	1.25	0.00	0.42	0.00	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	37.77	3.91	0.69	1.38	1.15	0.23	0.23	0.23	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	17.09	1.08	0.00	0.72	0.54	0.00	0.36	0.18	0.90	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	50.39	7.21	0.82	2.58	2.16	0.62	2.06	0.62	0.41	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	47.05	4.19	0.23	1.16	2.10	0.00	1.63	0.00	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	99.45	5.76	6.40	2.56	3.84	1.28	3.20	1.28	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	124.10	0.00	0.00	10.34	0.00	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	37.76	2.25	2.25	0.56	2.25	0.56	0.00	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	33.78	2.23	1.67	0.74	2.04	0.74	0.37	0.00	0.19	0.56
CD14+ Monocytes, donor3	11381-118B4	41.27	5.27	2.41	0.88	2.63	0.88	1.10	0.22	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	63.12	1.98	7.64	0.85	0.57	0.28	0.00	0.85	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	42.08	3.03	5.69	0.76	1.90	0.76	0.38	0.00	1.14	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	45.37	2.63	9.53	0.33	2.30	1.97	0.33	0.00	0.99	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	33.68	2.75	2.02	1.30	0.29	0.14	0.14	0.00	0.43	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	21.73	1.21	2.72	1.51	0.91	0.00	0.00	0.00	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	34.59	1.18	2.84	0.47	0.95	0.47	0.00	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	28.46	1.34	2.01	0.33	0.84	0.33	0.33	0.17	0.33	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	23.18	1.10	2.48	0.55	1.10	0.00	0.55	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	30.00	1.24	3.22	1.98	0.50	0.00	0.25	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	25.06	2.15	2.15	0.39	1.57	0.20	0.00	0.39	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	27.60	1.25	2.14	0.71	0.71	0.18	0.53	0.36	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	35.26	1.52	3.26	1.31	2.61	0.00	0.44	0.00	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	29.27	2.11	2.81	0.94	0.94	0.70	0.23	0.23	0.47	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	35.38	2.11	3.17	0.53	2.64	0.53	0.00	0.00	1.06	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	34.39	4.44	0.00	2.22	0.00	1.11	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	27.52	1.49	1.34	1.04	0.59	0.45	0.15	0.00	0.15	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	25.74	0.80	3.39	0.80	0.60	0.40	0.20	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	41.22	2.29	1.46	1.46	1.67	0.83	0.83	0.21	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	28.60	1.83	2.52	1.14	1.14	0.46	0.00	0.23	0.69	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	30.09	1.13	3.17	0.90	0.68	0.45	0.23	0.45	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	21.82	1.31	3.49	1.31	1.31	0.00	0.00	0.00	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	32.55	2.42	1.88	0.00	1.61	0.00	1.08	1.08	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	27.91	2.27	1.92	0.35	0.35	1.05	0.00	0.17	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	24.41	2.52	5.47	0.42	0.42	0.84	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	22.96	1.47	1.47	0.55	0.73	0.18	0.18	0.37	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	25.01	2.47	1.06	0.70	0.35	0.35	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	26.76	0.88	0.44	0.88	0.88	0.44	0.44	0.00	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	27.55	1.22	2.27	0.35	1.05	0.00	0.17	0.00	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	28.62	1.86	1.12	0.37	0.74	0.37	0.00	0.00	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	41.17	1.29	2.80	1.51	1.72	1.08	0.00	0.43	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	18.02	0.82	1.23	0.00	1.64	0.41	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	29.90	1.16	1.85	0.46	1.85	0.00	0.00	0.23	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	35.49	0.46	1.39	0.93	1.39	0.93	0.23	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	46.43	2.18	3.71	0.65	1.53	0.00	0.22	0.22	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	44.35	2.08	1.85	0.46	1.39	0.69	0.23	0.23	0.92	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	55.45	1.52	2.60	1.08	0.87	0.22	0.43	0.00	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	65.40	1.40	3.58	0.47	2.18	0.31	0.47	0.62	0.93	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	46.80	1.05	4.72	0.52	2.10	0.87	0.70	0.52	1.05	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	61.99	3.12	7.80	0.22	2.01	1.11	0.00	0.67	0.45	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	79.61	3.06	2.55	2.30	2.30	0.00	0.77	0.26	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	42.82	1.54	1.98	1.98	1.54	0.22	1.10	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	56.22	3.16	2.32	1.05	1.47	0.84	0.84	0.00	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	144.29	6.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	105.76	5.42	0.00	0.68	0.68	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	123.24	9.32	0.00	3.11	2.07	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	115.14	4.26	1.60	1.07	1.60	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	125.98	2.68	0.00	1.07	2.14	0.54	1.07	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	122.84	2.81	0.00	0.70	2.81	0.70	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	118.44	2.35	0.00	2.35	1.57	0.00	0.78	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	123.92	7.91	1.32	0.00	1.32	0.00	0.00	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	122.46	13.97	0.00	4.11	0.82	0.82	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	101.56	10.88	0.00	3.63	1.45	0.00	3.63	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	105.51	4.54	0.00	2.02	3.03	0.50	1.51	0.50	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	84.45	4.04	2.02	4.85	3.23	0.00	3.23	1.21	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	73.91	7.19	0.40	4.79	1.60	0.00	2.00	0.80	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	64.26	2.01	7.03	4.02	3.01	0.00	2.01	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	64.05	5.06	3.37	2.81	2.81	1.69	1.12	0.56	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	68.76	6.01	6.39	0.75	0.38	0.75	0.38	0.75	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	92.67	6.76	5.41	2.48	5.19	1.35	0.45	0.23	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	165.67	8.57	4.64	3.57	2.50	1.07	1.07	0.00	1.07	0.71
CD4+ T Cells, donor2	11306-117C1	160.44	14.08	3.06	5.51	4.29	0.00	0.00	1.22	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	96.99	4.57	0.91	3.66	1.22	0.91	1.22	0.61	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	112.05	3.57	6.13	0.51	2.30	0.26	0.00	0.00	0.26	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	126.22	2.70	3.14	1.12	1.80	0.67	0.22	0.00	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	132.52	2.59	3.74	1.44	2.30	0.00	0.86	0.00	0.86	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	252.69	7.59	3.79	7.59	4.27	0.95	3.79	0.95	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	309.72	12.64	2.11	4.21	2.11	0.00	0.00	0.00	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	161.51	3.30	0.00	3.30	6.59	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	99.86	4.05	4.34	0.72	2.02	0.72	0.29	0.14	0.58	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	87.10	3.90	3.56	1.19	3.22	0.68	0.68	0.17	0.51	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	89.31	3.71	3.71	1.13	1.93	0.16	0.81	0.64	0.81	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	161.39	8.07	3.14	4.03	2.69	0.90	0.90	0.00	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	176.79	5.94	2.45	1.05	4.19	0.00	0.35	0.35	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	137.27	3.52	2.64	0.88	3.52	0.00	0.44	0.44	1.32	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	104.15	3.79	2.53	0.00	1.26	1.69	1.69	1.26	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	83.94	2.29	2.29	1.04	1.87	1.04	0.42	0.21	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	78.19	3.68	2.00	1.34	3.68	1.00	1.00	0.33	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	211.29	11.42	4.62	2.18	4.89	0.00	0.82	0.27	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	209.02	5.90	4.82	2.68	1.07	0.54	1.07	0.54	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	129.11	8.97	1.79	5.38	1.79	0.00	0.00	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	103.47	2.41	3.89	1.67	2.23	1.67	0.37	0.74	0.74	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	109.61	2.38	3.90	0.22	2.60	0.43	0.43	0.43	1.08	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	125.67	2.10	3.15	0.63	3.36	0.42	0.00	0.42	0.00	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	242.18	5.56	1.52	3.03	7.08	0.00	0.51	0.51	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	214.03	8.67	3.47	2.17	4.33	0.43	0.43	0.00	0.87	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	163.87	4.79	1.74	2.61	2.18	0.44	0.00	0.87	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	188.05	6.93	2.47	1.48	4.95	0.00	1.48	0.99	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	168.94	4.62	0.00	2.77	0.00	0.00	1.85	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	195.42	15.35	2.79	1.40	2.79	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	150.65	3.32	6.92	1.11	1.11	0.83	1.38	1.11	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	150.18	4.66	5.64	0.49	3.44	0.98	0.98	1.23	0.49	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	124.74	3.08	3.08	3.08	4.62	1.54	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	159.36	5.73	4.66	1.79	2.51	1.07	1.43	0.00	0.00	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	168.97	5.54	4.15	4.15	4.15	0.00	1.38	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	141.43	11.46	3.93	7.20	2.62	0.98	1.31	0.00	0.65	1.64
CD8+ T Cells, donor2	11307-117C2	123.52	10.89	4.51	5.63	3.75	1.50	1.50	0.75	0.75	2.25
CD8+ T Cells, donor3	11383-118B6	143.41	12.62	2.52	7.57	1.26	0.00	1.26	0.25	0.00	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	22.02	3.44	2.98	1.15	0.69	2.29	0.23	0.00	0.46	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	23.01	3.12	3.83	2.16	1.68	1.20	1.20	0.48	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	29.82	5.20	3.56	1.92	1.64	2.74	0.55	0.00	0.27	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	33.02	3.00	3.30	0.90	2.10	3.30	0.00	0.30	1.50	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	26.64	3.60	4.08	0.72	1.20	2.40	0.48	0.24	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	22.97	2.96	5.00	1.36	0.23	1.59	0.23	0.23	1.59	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	22.60	3.69	6.08	1.09	1.30	1.52	1.52	0.00	1.09	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	20.27	2.11	4.21	2.37	0.53	2.11	0.53	0.26	0.79	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	16.18	2.35	4.69	2.58	0.70	2.58	1.17	0.00	1.17	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	23.24	2.42	3.92	3.02	1.21	0.91	1.51	0.00	1.21	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	25.27	3.49	4.65	1.16	1.16	0.87	1.16	0.58	2.03	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	20.78	3.20	5.33	1.60	1.60	1.33	0.80	0.00	2.13	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.51	3.06	6.13	0.88	0.88	2.19	1.31	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	18.67	1.82	7.74	0.91	0.46	3.19	0.46	0.00	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.92	4.48	9.70	2.98	1.49	0.00	0.00	0.00	2.98	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	23.77	3.96	6.12	2.52	0.36	1.80	0.72	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	22.73	2.59	4.03	2.30	1.15	2.30	0.29	0.29	1.15	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	22.63	1.65	5.42	1.18	1.18	0.71	0.47	0.00	2.12	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	27.25	2.22	5.39	0.63	0.32	2.22	1.58	0.32	1.58	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	25.84	2.15	5.84	1.23	1.23	1.54	1.23	0.00	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	24.36	2.24	4.17	0.64	1.28	2.56	0.64	0.00	1.60	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	32.51	4.97	5.74	1.53	0.38	4.21	1.53	0.38	0.76	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	26.41	5.12	6.31	1.58	1.18	3.15	0.39	0.39	3.15	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	23.45	1.51	4.54	1.51	2.27	2.27	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	48.98	6.42	6.42	2.41	2.41	4.01	1.61	0.00	3.21	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	56.65	3.50	6.29	2.10	0.70	6.29	1.40	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	61.11	7.01	10.02	2.00	1.00	6.01	1.00	0.00	3.01	0.00
Cardiac Myocyte, donor1	11525-119I4	7.31	3.66	1.83	1.83	0.00	0.00	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	22.23	2.47	1.48	0.49	0.49	0.99	0.00	0.00	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	19.68	2.00	0.63	0.63	0.53	0.63	0.21	0.95	0.42	0.00
Chondrocyte - de diff, donor1	11261-116G1	28.43	3.47	1.04	1.73	0.35	1.73	1.04	0.00	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	19.19	2.84	1.07	0.71	0.36	0.71	1.42	1.07	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	24.92	4.32	1.37	1.37	0.00	0.68	0.80	0.23	0.91	0.23
Chondrocyte - re diff, donor2	11339-117F7	24.17	5.37	8.06	0.00	0.00	0.00	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	35.99	4.04	0.40	0.81	0.81	0.00	0.40	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	47.40	4.13	2.64	1.26	1.49	1.26	0.69	0.92	0.34	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	32.71	4.28	1.71	2.57	0.86	1.07	0.86	0.00	0.86	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	29.82	3.72	2.30	1.42	0.88	1.24	0.80	0.53	0.44	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	54.20	4.49	4.13	2.75	1.38	0.92	0.83	0.73	0.55	0.09
Corneal Epithelial Cells, donor1	11526-119I5	30.52	1.98	0.88	1.32	1.10	0.00	0.88	0.44	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	40.95	0.00	0.00	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	32.98	3.58	0.51	2.30	0.77	0.00	0.51	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	23.28	0.99	3.80	0.17	0.83	0.17	0.33	0.33	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	23.02	1.26	3.47	0.32	0.63	1.26	0.00	0.32	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	58.66	3.45	3.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	19.33	0.86	4.10	0.32	1.19	0.97	0.00	0.22	0.54	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	96.68	4.78	5.12	1.37	4.44	0.34	1.37	0.68	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	103.81	3.92	3.26	1.96	2.61	0.00	0.00	0.65	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	114.69	2.42	3.87	0.97	2.90	0.00	1.45	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	20.01	3.00	1.50	0.83	0.50	0.17	0.50	0.83	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	25.23	1.17	1.76	1.17	1.17	0.00	0.59	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	18.95	0.28	0.85	0.00	0.85	0.00	0.00	0.00	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	18.87	2.36	1.57	1.18	0.39	0.39	0.79	0.39	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	13.67	1.75	0.58	1.16	0.00	0.29	0.00	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	24.94	2.12	1.18	0.71	0.24	0.47	0.24	0.24	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	23.14	1.93	1.23	0.53	0.35	0.70	0.18	0.53	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	20.84	0.89	1.55	1.11	0.22	1.11	0.22	0.44	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	24.04	2.13	2.13	1.22	0.30	0.30	0.30	0.30	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	24.81	3.66	2.82	0.56	0.00	0.56	0.28	0.28	1.13	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	16.34	0.00	0.89	0.30	0.00	0.59	0.00	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	30.20	2.60	0.52	0.00	1.04	0.00	1.04	1.56	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	15.45	0.99	0.28	0.43	0.28	0.28	0.57	0.28	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	22.81	2.80	1.20	0.00	0.80	1.60	0.80	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	15.72	0.00	0.52	0.52	0.00	0.00	0.00	0.00	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	43.24	3.73	3.35	0.87	0.50	1.74	0.75	0.50	0.50	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	19.12	3.04	1.52	0.43	0.65	0.65	0.22	0.43	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	25.65	3.30	1.83	0.73	1.83	0.73	0.61	0.49	0.49	0.12
Endothelial Cells - Vein, donor1	11267-116G7	34.13	4.55	2.28	1.14	2.28	0.00	2.28	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	29.34	2.79	1.40	0.70	0.00	0.70	0.00	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	18.06	2.20	1.88	0.47	0.79	0.00	0.16	0.31	0.47	0.00
Eosinophils, donor1	12244-129H3	167.72	0.00	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	52.81	3.30	1.65	8.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	21.40	3.57	0.00	0.00	3.57	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	25.17	2.20	0.49	0.98	0.49	0.49	0.73	0.00	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	35.36	4.16	0.00	2.08	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	24.63	5.75	2.87	2.46	0.41	0.00	0.82	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.12	0.77	0.88	0.77	0.22	0.33	0.11	0.00	0.11	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	15.71	1.95	1.73	0.98	0.22	1.19	0.43	0.22	0.22	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	23.29	3.27	1.21	0.61	0.49	0.49	0.85	0.24	0.24	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	88.02	9.83	3.28	4.64	2.05	0.82	1.50	1.36	1.64	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	19.20	2.95	0.84	1.05	0.32	0.21	0.11	0.42	0.42	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	53.75	6.85	1.58	3.16	1.58	0.53	0.79	1.32	1.32	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	20.60	1.00	0.33	0.66	0.66	1.00	0.00	0.66	1.00	0.66
Fibroblast - Cardiac, donor1	11268-116G8	22.68	1.81	1.81	1.36	0.91	0.00	1.81	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	25.77	1.52	2.27	0.76	1.52	0.00	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	28.86	2.84	0.95	1.42	0.95	0.32	0.32	0.32	0.16	0.32
Fibroblast - Cardiac, donor4	11452-119A3	40.01	7.58	2.12	1.82	2.12	0.91	1.21	0.61	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	23.10	2.54	2.03	0.76	0.38	1.02	1.40	0.38	0.76	0.25
Fibroblast - Cardiac, donor6	11460-119B2	20.62	2.27	1.67	0.76	0.76	1.52	0.45	0.15	0.61	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	30.01	3.75	1.61	1.34	0.67	1.88	0.94	0.13	0.40	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.51	3.45	1.29	0.43	0.86	0.00	0.43	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	2.93	1.46	1.46	1.46	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	61.35	9.23	2.54	3.23	0.46	1.15	0.69	0.69	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	33.92	2.71	0.68	1.70	0.17	0.85	0.68	0.17	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	16.67	0.70	1.41	0.23	0.70	0.23	0.00	0.00	0.00	0.70
Fibroblast - Dermal, donor2	11346-117G5	33.02	1.89	0.47	1.42	0.47	0.94	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	18.98	1.93	1.09	0.97	0.12	0.48	0.24	0.12	0.48	0.12
Fibroblast - Dermal, donor4	11450-119A1	21.48	2.71	1.36	0.90	0.79	0.90	0.79	0.11	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	26.17	3.14	1.92	1.40	0.70	0.70	0.52	0.35	0.35	0.35
Fibroblast - Dermal, donor6	11458-119A9	27.12	1.62	1.62	0.81	0.49	0.65	0.32	0.16	0.49	0.16
Fibroblast - Gingival, donor1	11237-116D4	31.65	2.92	1.46	0.83	0.21	0.21	0.42	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	39.04	6.55	0.79	1.83	0.79	0.52	1.83	0.79	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	31.63	2.37	0.79	0.66	0.66	0.40	0.00	0.00	0.13	0.26
Fibroblast - Gingival, donor3	11394-118C8	33.26	3.19	2.42	1.06	0.97	0.68	0.68	0.29	0.48	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	30.13	1.04	2.08	1.04	0.00	0.00	1.04	0.00	0.00	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	22.38	2.64	1.76	1.41	0.00	0.53	1.06	0.35	0.35	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	40.53	3.12	3.12	0.78	0.31	0.94	0.47	0.31	0.78	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	33.13	4.06	2.98	2.98	1.49	0.41	0.68	0.41	0.27	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	77.28	6.35	2.82	6.35	2.47	0.71	1.06	1.06	0.71	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	37.00	4.53	2.92	2.92	1.17	1.17	0.88	0.58	0.58	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	36.41	4.64	1.91	3.14	1.77	1.09	0.95	0.68	0.82	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	37.95	5.27	2.19	2.74	1.32	1.43	1.86	0.66	0.88	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	43.73	5.28	1.76	3.23	0.88	0.00	1.76	0.15	0.44	1.17
Fibroblast - Lung, donor1	11270-116H1	46.22	0.00	0.00	0.00	1.36	0.00	0.00	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	26.86	0.00	0.00	0.00	1.49	0.00	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	26.80	2.32	0.63	0.42	0.42	0.00	0.42	0.00	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	42.48	3.33	1.67	0.83	0.00	2.50	2.50	2.50	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	16.78	1.40	0.00	1.40	0.00	1.40	1.40	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	21.83	3.08	0.56	0.84	0.56	0.00	1.12	0.28	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	54.81	5.68	3.25	1.62	0.81	1.22	0.00	0.81	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	27.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00	5.96	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	32.59	2.52	1.94	0.97	0.97	0.58	0.39	0.00	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	37.01	3.94	1.06	0.46	0.76	0.30	0.46	0.46	0.15	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	37.94	2.75	2.14	2.14	0.31	0.92	0.31	0.61	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	30.15	4.20	1.53	0.38	1.53	0.38	0.00	0.76	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	28.35	6.75	1.35	1.62	0.54	0.54	1.35	0.27	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	24.70	3.13	0.70	1.39	0.58	0.35	0.46	0.12	0.23	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	21.89	1.44	2.10	0.88	0.55	0.55	0.11	0.22	0.66	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	45.51	1.83	3.45	0.81	1.22	0.41	0.81	0.41	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	24.72	2.67	1.34	0.00	0.67	0.00	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	20.56	3.16	1.19	0.79	0.40	0.40	0.79	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	68.66	7.74	1.79	4.56	3.57	1.19	1.59	1.19	0.99	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	25.93	3.55	1.95	1.42	0.00	0.18	0.53	0.00	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	26.02	3.35	0.79	1.58	0.59	0.20	0.79	0.79	0.59	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	49.04	6.32	1.81	1.20	0.60	0.60	0.60	0.60	1.20	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	27.74	4.32	1.94	1.84	0.65	0.97	1.73	0.43	0.43	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	71.37	8.35	3.04	4.81	2.53	0.76	2.02	0.51	1.77	0.25
Fibroblast - skin normal, donor1	11553-120C5	23.46	2.30	1.48	1.48	0.49	0.33	0.33	0.49	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	84.21	7.42	2.21	3.01	2.41	1.40	1.60	0.60	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	24.81	2.41	1.21	1.61	0.80	0.80	1.31	0.60	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	65.28	8.76	2.72	2.72	2.12	0.60	1.81	1.51	0.60	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	40.10	4.89	2.24	1.91	0.91	0.50	0.99	0.33	0.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	40.34	3.76	2.05	2.39	0.51	0.85	1.20	0.17	0.17	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	54.85	5.91	3.28	2.63	1.31	0.66	1.64	0.66	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	25.14	3.09	2.66	1.38	1.17	1.07	0.85	0.00	0.53	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	24.46	3.04	1.35	1.52	0.84	0.84	0.17	0.34	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	16.15	2.35	1.41	0.78	0.47	0.47	0.16	0.31	0.31	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	25.27	0.00	0.87	0.00	0.00	0.00	0.00	0.00	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	24.44	2.43	2.43	2.08	1.21	0.52	1.21	0.17	0.35	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	24.46	4.94	3.64	2.60	0.78	0.26	1.30	0.78	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	27.34	3.83	1.02	3.07	0.77	0.51	0.77	0.00	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	41.34	5.36	0.77	5.36	0.00	0.00	2.30	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	47.86	5.10	0.64	5.10	1.28	0.64	1.28	0.64	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	51.35	5.13	6.28	2.57	2.00	0.00	2.85	0.86	1.71	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	99.27	10.48	2.21	2.21	1.10	0.55	1.93	0.28	0.55	12.13
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	66.44	5.94	2.97	5.48	2.28	0.68	1.37	0.23	0.46	7.99
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	39.63	3.76	2.77	1.78	0.20	0.79	1.19	0.99	0.59	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	66.35	6.61	1.32	3.44	0.53	0.26	1.32	0.53	0.00	12.95
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	61.32	8.15	1.63	3.59	1.30	1.63	2.61	0.65	0.33	8.48
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	38.03	5.31	1.33	1.77	0.88	0.44	1.77	0.00	0.44	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	48.05	2.54	1.84	0.85	1.27	0.71	2.69	0.28	0.42	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	42.24	2.46	2.46	2.59	1.23	1.48	1.60	0.49	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	35.73	3.49	1.34	1.88	0.81	0.81	2.42	0.27	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	37.66	3.72	2.23	1.36	0.62	0.37	1.86	0.37	0.25	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	42.77	5.26	1.38	1.52	0.97	0.55	1.52	0.42	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	31.11	6.10	1.02	0.61	0.81	0.20	2.03	0.20	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	41.30	2.74	2.28	1.14	0.91	2.51	0.91	0.23	0.68	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	39.11	3.61	1.74	1.74	0.50	1.25	1.37	0.50	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	36.07	2.84	1.97	0.22	0.66	1.31	0.87	0.22	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	51.12	6.21	2.07	1.77	0.59	2.07	0.59	1.18	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	45.30	3.34	1.59	1.43	0.32	0.32	1.43	0.16	0.48	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	40.22	3.57	2.68	1.12	1.12	1.79	0.89	0.00	0.67	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	43.35	5.65	1.61	2.02	0.81	1.61	2.02	1.21	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	43.60	5.09	2.71	2.54	0.51	1.53	0.51	0.34	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	50.72	4.79	4.61	2.13	1.33	2.04	0.71	0.80	0.53	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	55.77	6.14	4.68	3.23	1.25	1.87	1.77	0.10	0.62	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	50.55	4.44	3.42	3.76	1.02	2.05	1.88	0.17	0.85	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	40.39	3.21	2.32	2.21	0.33	1.00	1.44	0.22	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	46.76	4.33	3.00	2.25	0.83	1.58	1.25	0.33	0.33	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	44.51	4.70	2.65	1.43	1.02	1.84	0.61	0.00	1.02	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	48.28	5.78	2.06	2.06	0.41	2.06	0.83	0.41	0.21	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	39.66	4.61	1.96	1.50	0.58	0.69	1.61	0.12	0.35	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	39.86	5.67	4.17	2.00	0.50	0.50	1.33	0.33	0.33	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	44.75	3.53	2.20	1.76	0.44	1.32	0.88	0.44	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	49.81	5.66	2.95	2.58	0.98	1.72	1.97	0.61	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	47.01	6.81	2.27	3.08	0.81	0.97	1.30	0.32	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	46.18	4.49	1.60	2.57	0.32	1.28	1.92	0.00	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	33.83	4.74	1.71	2.08	0.47	1.14	1.52	0.09	0.19	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	34.17	3.95	2.53	1.11	0.63	0.79	0.95	0.00	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	41.96	2.74	4.26	2.13	0.00	0.91	0.61	0.91	0.30	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	36.07	3.55	2.51	1.88	0.52	0.52	1.36	0.42	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	39.08	5.71	2.20	2.63	0.88	2.20	1.76	0.44	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	40.68	5.05	2.52	3.65	0.56	1.12	2.24	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	32.96	2.69	3.06	1.57	0.56	0.83	0.56	0.46	0.56	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	34.23	4.81	2.41	2.41	0.80	2.94	1.34	0.00	0.27	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	34.89	5.51	3.83	0.77	0.77	1.53	0.77	0.77	0.77	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	33.94	3.89	2.85	2.20	0.78	0.52	1.04	0.52	0.52	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	34.97	5.96	1.90	2.44	0.54	1.36	0.81	0.54	1.08	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	38.53	4.61	1.66	1.66	0.74	1.66	1.47	0.18	0.74	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	35.75	3.29	1.32	1.54	0.00	0.88	0.88	0.22	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	67.44	7.93	2.98	4.96	0.00	0.99	4.96	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	36.94	3.43	1.19	1.98	0.92	0.40	0.53	0.53	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	30.47	4.04	1.01	1.41	0.61	1.61	0.61	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	93.53	10.17	5.34	2.80	0.00	1.52	3.30	0.51	0.76	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	48.37	3.38	2.79	1.59	1.79	1.00	1.59	0.20	0.40	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	50.07	4.31	2.62	1.39	1.69	0.15	0.62	0.31	0.77	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	63.42	4.09	2.05	1.84	1.23	1.23	2.25	0.20	0.41	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	79.80	5.63	1.25	3.13	0.94	0.94	1.56	0.63	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	64.71	6.50	1.70	1.98	3.39	1.13	2.54	0.57	0.57	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	42.89	1.38	2.31	1.84	1.84	0.46	2.77	0.92	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	64.34	4.95	2.47	0.00	0.00	0.00	0.00	2.47	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	51.45	3.87	1.55	3.09	1.16	1.16	1.55	0.39	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	68.99	14.44	3.21	8.02	4.81	1.60	0.00	0.00	3.21	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	41.73	6.96	1.74	0.00	3.48	3.48	3.48	0.00	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	45.57	3.91	3.58	0.00	1.63	1.30	1.63	0.33	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	47.36	4.94	3.29	1.65	1.24	1.65	1.65	0.00	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	10.00	0.00	0.00	0.00	0.00	0.00	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	53.13	5.03	1.96	1.96	1.68	0.84	0.84	0.56	0.84	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	48.70	8.82	2.29	2.61	1.96	2.61	1.96	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	52.85	5.03	2.52	0.00	0.84	0.84	0.84	0.00	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	49.94	5.09	4.13	2.86	1.59	0.64	2.23	0.64	0.00	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	58.08	5.43	1.70	2.38	2.04	1.36	1.36	0.34	1.02	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	87.70	8.35	4.18	4.18	2.09	0.00	2.09	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	59.56	4.58	1.72	1.15	0.57	0.00	4.01	1.15	0.00	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	56.24	5.03	1.78	2.37	0.30	0.00	2.07	0.59	0.30	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	74.54	11.86	3.39	5.08	0.00	0.00	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	62.13	7.46	2.90	2.07	0.41	1.24	2.90	0.83	0.41	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	50.17	7.13	2.76	2.99	2.76	2.76	2.07	0.69	0.00	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	5.27	0.00	5.27	5.27	5.27	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	49.20	8.46	3.84	2.31	1.15	3.08	0.77	0.00	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	55.41	6.85	2.61	4.56	1.96	1.63	1.63	0.00	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	74.24	7.36	3.34	4.01	0.67	0.67	1.34	0.67	0.00	4.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	63.57	3.85	0.77	3.08	0.00	1.93	3.47	0.39	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	47.93	4.79	2.40	3.77	1.37	1.37	0.68	0.34	0.34	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	82.00	2.48	2.48	0.00	2.48	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	76.91	7.08	2.83	1.89	2.36	0.94	0.47	0.47	0.47	3.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	65.78	7.85	2.41	3.62	3.02	0.60	0.60	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	65.62	6.61	2.03	3.05	1.53	0.51	3.56	0.51	1.02	4.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	66.61	9.17	3.19	3.99	1.60	0.40	1.99	0.80	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	67.10	5.92	1.97	3.95	1.48	0.99	1.97	0.49	0.00	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	76.73	3.54	4.72	3.54	2.36	1.18	2.36	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	68.85	11.67	1.75	2.33	2.92	1.75	2.33	0.00	0.00	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	61.00	4.39	1.76	2.63	2.63	0.88	0.88	0.00	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	45.78	10.17	1.70	5.09	0.85	1.70	0.85	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	54.32	7.76	2.98	7.76	0.60	2.39	1.79	1.19	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	34.94	2.91	3.88	2.43	0.97	1.94	0.49	0.49	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	27.39	3.42	2.28	0.00	0.00	2.28	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	24.95	1.66	0.83	0.83	0.83	0.00	0.42	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	66.34	9.00	2.25	6.75	3.37	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	20.93	2.22	0.63	2.22	0.32	0.32	0.63	0.00	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	17.96	0.84	0.00	0.84	1.67	0.42	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	32.03	2.55	9.17	1.97	1.51	2.32	0.81	0.35	1.04	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	26.00	2.53	5.57	1.52	1.01	1.86	0.34	0.00	0.84	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	22.07	1.37	7.28	0.68	2.28	0.46	0.00	0.00	0.68	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	34.00	2.30	8.31	1.20	1.53	2.08	0.33	0.33	0.98	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	30.95	2.36	7.74	0.64	1.07	1.29	0.21	0.21	2.36	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	24.76	2.58	6.67	0.65	1.08	2.15	1.08	0.22	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	27.15	1.74	7.47	2.24	1.25	1.99	0.37	0.25	1.62	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	25.56	2.92	6.69	2.06	0.69	1.72	0.86	0.34	1.03	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	16.98	2.56	5.77	0.96	0.64	2.56	0.32	0.00	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	24.06	2.24	4.48	0.00	0.00	2.80	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	22.51	2.16	0.87	0.00	0.87	0.87	0.87	0.87	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	7.93	2.64	0.00	5.29	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	38.09	1.76	1.06	0.35	2.12	0.71	0.00	1.41	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	36.33	1.45	0.73	1.45	0.73	0.00	0.73	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	18.88	3.67	1.05	1.22	1.57	0.87	1.05	0.35	0.52	0.17
Hepatocyte, donor1	11523-119I2	25.42	2.42	1.21	2.42	1.21	0.00	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	25.86	1.08	2.15	2.15	0.00	1.08	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	30.06	1.23	2.45	0.61	0.61	0.00	1.23	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	47.65	3.26	1.31	1.31	1.96	0.65	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	65.89	4.89	9.96	2.80	2.97	3.15	1.05	2.45	0.87	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	19.21	2.74	1.65	0.27	0.55	0.55	0.14	0.14	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	194.22	22.29	9.55	0.00	15.92	0.00	0.00	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	280.36	0.00	0.00	6.68	80.10	0.00	0.00	6.68	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	243.75	108.33	0.00	0.00	0.00	0.00	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	146.74	16.61	4.15	4.15	15.23	0.00	2.77	5.54	4.15	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	197.71	10.01	5.01	5.01	12.51	0.00	5.01	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	118.68	11.87	0.00	11.87	11.87	0.00	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	238.35	15.38	7.69	5.13	15.38	2.56	5.13	7.69	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	228.54	13.71	0.00	9.14	27.42	0.00	0.00	13.71	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	232.28	22.74	3.25	3.25	19.49	1.62	6.50	11.37	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	100.04	13.34	3.33	6.67	5.00	0.00	0.00	0.00	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	221.46	25.41	0.00	0.00	7.26	0.00	3.63	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	252.78	17.21	3.97	3.97	27.79	3.97	1.32	3.97	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	121.95	12.20	3.33	1.11	6.65	1.11	3.33	3.33	1.11	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	246.20	41.91	5.24	10.48	10.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	142.98	7.56	1.89	3.78	11.97	1.89	2.52	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	133.01	9.28	0.00	3.09	13.92	1.55	1.55	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	234.16	29.27	14.63	0.00	14.63	0.00	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	165.39	14.86	1.94	4.52	9.69	0.65	1.94	3.23	1.94	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	172.26	12.88	4.83	9.66	20.93	0.00	4.83	8.05	3.22	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	250.91	11.95	0.00	35.84	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	189.87	10.59	3.26	4.89	17.93	0.00	4.07	4.07	2.44	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	187.24	12.59	2.10	7.14	16.79	1.68	1.26	5.04	1.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	258.70	14.37	14.37	0.00	14.37	0.00	28.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	165.56	12.86	3.21	5.63	16.88	0.00	4.82	3.21	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	78.48	5.54	0.92	4.62	8.31	0.00	0.92	0.92	1.85	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	135.73	30.16	15.08	0.00	0.00	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	94.41	8.02	2.83	1.42	6.61	0.00	1.42	3.30	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	79.81	7.26	2.72	2.72	8.16	1.81	1.81	1.81	2.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	14.74	0.00	0.00	0.00	0.00	14.74	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	137.74	12.91	5.38	2.15	13.99	0.00	2.15	6.46	3.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	128.32	10.16	3.81	1.27	12.70	1.27	0.00	2.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	0.00	0.00	0.00	16.43	0.00	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	130.72	10.84	1.28	4.46	16.58	1.28	3.19	5.10	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	129.41	9.11	3.65	1.82	16.40	0.00	0.00	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	126.43	0.00	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	139.96	12.14	2.14	3.57	9.28	0.00	3.57	5.00	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	149.32	13.27	3.32	0.00	6.64	0.00	3.32	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	166.79	0.00	0.00	20.85	20.85	0.00	0.00	41.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	67.60	4.32	1.85	1.23	5.25	0.62	0.93	2.47	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	145.75	17.56	5.27	1.76	14.05	1.76	0.00	3.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	154.01	18.86	3.14	0.00	15.72	3.14	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	141.86	13.21	0.70	3.48	7.65	0.70	1.39	0.70	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	314.26	33.20	8.85	11.07	19.92	2.21	8.85	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	226.94	22.69	6.48	9.73	19.45	6.48	9.73	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	324.36	27.90	1.74	5.23	22.67	0.00	3.49	7.85	2.62	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	380.21	24.75	11.25	9.00	40.50	0.00	4.50	6.75	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	390.27	24.39	3.48	6.97	34.85	0.00	0.00	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	361.64	23.47	6.40	7.47	19.20	0.00	4.27	6.40	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	227.21	19.40	5.54	6.93	8.31	1.39	2.77	4.16	2.77	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	250.76	14.25	2.85	11.40	19.95	0.00	8.55	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	251.28	24.85	0.00	4.60	19.33	0.00	1.84	3.68	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	390.27	30.25	9.08	3.03	12.10	0.00	3.03	6.05	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	502.90	80.71	6.21	0.00	37.25	0.00	6.21	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	375.37	45.47	3.17	4.23	24.32	0.00	9.52	4.23	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	30.93	3.59	1.71	3.84	0.82	1.71	0.33	0.24	0.41	0.24
Keratinocyte - epidermal, donor2	11349-117G8	33.38	2.34	0.00	0.59	0.59	0.59	1.17	0.59	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	24.71	2.37	1.51	1.51	0.95	0.38	0.57	0.00	0.19	0.09
Keratinocyte - oral, donor1	11251-116E9	33.71	2.50	2.61	0.57	0.68	0.68	0.45	0.45	0.34	0.00
Keratocytes, donor1	11527-119I6	59.83	4.81	2.06	0.69	1.72	0.34	1.03	0.69	0.69	0.00
Keratocytes, donor2	11607-120I5	28.12	1.17	3.52	1.17	3.52	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	30.03	3.95	1.38	0.59	0.79	1.19	0.00	0.00	0.40	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	21.98	0.00	4.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	18.34	3.24	0.00	1.08	0.00	0.00	0.00	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	33.91	4.04	3.11	1.15	0.69	0.58	0.58	0.46	0.46	0.00
Lens Epithelial Cells, donor3	11690-122I7	31.79	5.55	2.42	1.82	0.50	1.21	0.50	0.10	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	28.93	3.79	1.42	0.71	0.71	0.71	0.59	0.36	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	22.61	2.79	1.67	1.12	0.28	0.28	0.28	0.00	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	26.76	2.36	2.83	0.47	1.10	0.47	0.79	0.31	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	23.66	1.08	0.54	1.61	0.54	0.00	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	22.69	3.15	1.58	0.95	1.58	0.00	0.63	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	20.16	2.16	1.19	0.32	0.65	0.22	0.22	0.22	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	23.39	2.05	1.23	1.23	0.00	0.41	0.41	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	28.57	4.30	0.76	0.25	1.01	0.00	0.76	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	22.10	2.67	1.27	0.56	0.99	0.14	0.84	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.59	1.98	1.19	0.00	0.40	0.00	0.79	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	22.30	2.33	0.97	0.97	0.58	0.00	0.19	0.58	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	19.63	1.30	1.67	0.37	0.74	0.19	0.00	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	20.21	2.44	1.39	1.05	0.35	0.00	0.35	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	30.53	1.91	1.43	0.24	0.48	0.24	0.95	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	22.80	1.79	1.37	0.69	0.82	0.55	0.82	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.17	1.23	0.92	0.62	0.92	0.00	0.31	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	30.55	2.49	0.00	0.94	0.94	0.00	0.94	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	28.55	1.83	1.28	0.55	0.55	0.37	0.55	0.18	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	19.09	1.97	1.32	0.99	0.00	0.00	0.66	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	25.77	4.10	0.29	0.88	0.00	0.00	0.29	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	24.15	2.49	1.49	0.75	1.00	0.50	0.25	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	16.49	1.45	1.45	1.45	0.48	0.00	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	23.16	2.69	1.62	1.62	0.54	0.27	0.00	0.27	0.54	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	22.86	1.51	1.97	0.91	0.91	0.76	0.91	0.61	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	23.85	2.07	0.52	0.52	2.07	0.00	0.52	0.00	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	26.38	1.88	1.05	1.05	1.05	0.00	1.05	0.00	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	18.50	2.11	1.50	0.75	0.75	0.45	0.90	0.00	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	28.20	1.38	2.06	0.00	0.69	0.69	0.69	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	23.14	3.39	0.75	0.75	1.32	0.00	0.56	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	21.21	1.91	0.53	0.74	0.74	0.32	0.42	0.11	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.51	2.91	0.97	1.45	0.00	0.97	0.48	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	19.19	0.00	0.66	0.99	0.99	0.00	1.32	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	23.91	3.10	0.99	1.12	0.37	0.50	0.87	0.25	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	24.80	1.85	2.22	0.74	0.37	1.11	0.74	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	25.70	5.68	0.74	0.99	0.99	0.00	1.24	0.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	20.90	2.06	1.51	0.69	0.82	0.27	0.00	0.41	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	23.16	2.57	1.93	0.32	0.00	0.96	0.64	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	25.87	1.52	0.61	1.83	0.61	0.00	0.91	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	21.41	1.40	1.40	0.98	0.70	0.28	0.42	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	20.98	3.56	1.78	0.71	0.00	0.00	0.71	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	22.78	4.85	0.48	0.00	0.00	0.00	0.97	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	23.03	1.71	0.78	1.09	0.78	0.00	0.62	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	23.99	1.07	0.00	0.36	1.79	1.43	1.07	0.36	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	26.79	3.27	1.31	2.29	0.33	0.00	0.00	0.33	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	22.60	2.59	1.41	1.88	0.24	0.47	0.24	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	28.59	2.10	1.73	0.62	0.74	0.37	0.62	0.25	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	26.64	4.10	1.54	2.05	1.54	0.26	0.26	0.00	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	25.06	1.49	1.19	0.30	0.30	0.30	0.30	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	133.69	4.53	0.00	4.53	9.06	0.00	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	59.07	9.21	1.53	0.77	5.37	0.77	1.53	3.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	53.44	5.20	1.48	3.71	1.48	0.74	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	65.16	7.62	3.39	3.81	3.81	0.42	1.69	0.85	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	55.56	6.33	2.81	2.11	2.81	0.00	2.11	0.70	0.70	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	56.97	4.67	2.80	3.74	3.74	0.00	0.93	1.87	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	51.53	2.58	1.03	1.55	1.03	0.00	2.58	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	61.85	3.57	2.38	1.19	2.38	0.00	0.00	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	70.12	4.75	1.58	1.13	4.52	0.68	1.13	0.45	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	34.32	3.78	1.74	1.45	2.91	0.29	0.00	0.87	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.96	3.15	2.25	1.35	2.70	1.35	1.35	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	73.98	4.06	1.76	2.71	2.44	0.54	0.68	0.27	1.08	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	59.57	6.16	2.05	4.11	2.57	1.03	3.08	0.51	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	35.64	2.12	1.41	1.76	1.41	1.06	0.71	1.41	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	37.98	6.00	2.00	2.00	4.00	0.00	0.67	2.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	69.28	3.06	2.04	3.57	4.08	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	36.29	1.87	1.87	1.33	1.07	0.53	1.60	0.53	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	39.49	2.46	3.40	1.51	0.94	0.94	0.57	0.38	0.76	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	76.08	3.68	1.84	3.07	4.29	1.23	1.23	0.61	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	79.91	4.89	0.82	2.45	2.45	1.63	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	30.82	5.00	0.83	1.87	1.04	0.42	1.87	0.62	0.42	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	33.35	2.24	3.08	1.40	1.40	0.56	0.84	0.28	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	68.00	1.03	5.15	1.03	4.12	1.03	1.03	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	30.77	1.74	1.45	0.87	1.16	0.29	0.87	0.58	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	32.28	6.58	1.49	2.39	1.49	0.30	0.90	0.30	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	21.02	2.77	2.21	0.55	1.66	1.11	1.11	1.11	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	56.20	4.95	2.47	1.77	1.77	0.00	2.83	0.71	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	47.20	3.69	2.95	1.84	1.84	1.11	1.11	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	62.17	3.45	1.15	0.00	1.15	0.00	2.30	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	60.25	3.07	1.54	1.54	2.30	0.38	1.15	0.77	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	57.18	3.96	2.26	2.83	1.70	0.57	1.70	0.57	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	59.07	4.10	0.82	4.10	1.64	0.82	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	61.91	6.33	1.81	4.07	2.26	0.45	0.45	0.45	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	62.48	5.75	2.87	2.15	3.59	0.72	0.72	1.44	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	63.49	4.48	2.99	0.75	5.23	0.00	0.75	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	54.25	4.09	3.72	1.11	1.49	0.37	1.86	1.49	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	44.80	3.02	2.58	0.86	3.02	0.00	0.00	0.43	1.29	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	72.79	6.85	1.71	3.43	2.57	0.00	2.57	0.86	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	63.97	4.66	2.33	3.33	3.33	0.33	1.00	0.33	2.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	79.03	7.84	4.83	3.62	3.62	0.00	1.21	1.81	1.81	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	71.10	3.55	2.13	1.42	5.69	0.00	0.00	1.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	70.81	6.19	1.72	3.78	3.44	0.69	1.37	0.69	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	73.00	6.44	4.83	2.68	2.15	1.61	2.68	1.07	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	86.86	4.71	4.04	2.69	4.04	0.67	0.67	1.35	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	64.82	7.04	2.59	2.22	2.22	1.48	0.74	1.11	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	110.48	3.49	0.00	4.65	6.98	0.00	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	110.01	3.17	5.29	1.06	4.23	0.00	2.12	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	63.22	4.80	2.00	2.80	3.60	0.40	1.20	0.40	1.20	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	88.68	10.18	2.18	7.27	2.18	1.45	2.18	1.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	108.08	8.43	3.83	0.00	5.37	4.60	1.53	1.53	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	75.96	6.91	3.45	2.96	3.45	0.49	0.99	1.48	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	86.57	2.82	3.76	3.76	2.82	0.00	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	78.94	5.03	3.02	2.51	6.03	1.01	0.50	0.50	1.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	64.44	6.76	1.35	1.80	2.25	0.45	1.35	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	53.35	5.16	0.00	0.00	0.00	0.00	0.00	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	60.57	4.45	1.34	4.90	5.79	0.45	1.34	0.89	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	63.74	7.04	1.96	1.96	6.26	2.35	1.56	0.78	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	66.63	4.62	3.30	5.28	3.96	3.30	2.64	0.66	1.98	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	71.61	6.23	1.56	3.11	3.11	0.00	1.04	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	61.70	3.94	1.75	1.75	2.19	0.44	0.44	0.88	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	46.96	1.68	2.24	1.68	3.91	1.12	1.68	0.00	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	54.32	6.18	0.88	0.88	2.21	0.44	0.44	0.00	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	50.14	3.47	4.63	3.09	3.09	1.54	1.54	0.39	1.93	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	42.53	6.58	2.03	4.05	2.03	0.00	1.01	1.01	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	49.50	1.44	2.88	0.96	0.96	0.48	0.96	0.96	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	58.84	5.17	1.59	1.99	2.39	1.59	2.78	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	52.26	5.47	2.43	5.47	3.04	0.61	0.00	0.00	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	32.51	2.77	4.84	2.08	0.00	0.69	0.00	1.38	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	41.80	7.22	2.28	2.66	1.52	0.00	0.00	0.76	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	55.77	5.16	2.58	1.03	2.07	0.00	1.03	1.03	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	44.14	4.84	1.81	2.42	3.02	0.60	0.00	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	47.85	2.54	2.85	2.22	1.58	1.27	1.27	0.95	0.63	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	67.70	5.86	3.73	8.00	2.67	0.00	2.13	1.60	0.00	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	67.24	3.45	2.30	3.45	5.17	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	56.57	4.63	1.54	4.11	2.06	0.00	1.03	0.00	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	58.00	4.95	0.71	1.41	2.12	0.00	2.12	0.71	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	61.29	3.97	1.70	5.11	5.11	0.00	1.13	0.00	1.70	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	60.32	8.74	4.99	4.58	1.66	0.00	2.50	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	63.43	3.92	3.13	1.57	3.13	0.00	1.57	0.00	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	59.29	4.59	3.76	2.09	3.76	0.42	1.25	2.51	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	66.44	6.50	0.93	0.93	1.39	0.00	2.79	0.46	0.93	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	58.88	9.37	1.34	2.01	3.35	0.00	1.34	0.67	2.68	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	49.72	3.74	2.14	2.14	1.60	0.00	1.07	1.07	1.60	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	63.04	6.06	1.62	3.23	2.83	0.81	1.21	1.21	1.62	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	83.52	8.26	2.75	5.51	2.75	0.00	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	79.13	5.33	3.56	1.78	0.89	1.78	2.67	0.00	0.89	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	83.77	3.99	3.42	0.57	3.99	0.57	0.00	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	83.59	6.14	6.14	3.07	1.53	0.77	0.77	0.00	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	55.26	4.92	1.09	1.64	1.64	1.09	1.64	0.00	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	64.59	5.35	2.67	1.34	1.78	0.89	0.45	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	94.88	5.46	3.12	4.94	7.28	0.78	1.56	1.30	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	75.59	5.30	4.64	2.65	4.64	0.00	0.00	0.66	2.65	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	74.83	4.16	2.08	2.08	4.16	0.00	2.08	6.24	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	24.16	1.14	6.61	0.23	1.14	0.91	0.00	0.23	0.91	0.00
Macrophage - monocyte derived, donor2	11313-117C8	17.07	0.92	3.30	0.37	0.73	0.18	0.00	0.37	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	19.01	1.97	3.01	0.66	0.79	0.26	0.13	0.26	0.79	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	23.90	0.53	1.06	1.59	0.00	1.59	0.53	0.53	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	33.12	3.17	4.28	5.07	0.16	1.74	1.74	1.27	1.43	0.16
Mallassez-derived cells, donor3	11930-125I4	27.10	2.78	3.75	2.50	1.11	1.39	0.83	0.69	0.00	0.56
Mammary Epithelial Cell, donor1	11273-116H4	39.36	3.99	2.19	1.69	1.30	2.69	0.50	0.20	0.40	0.10
Mammary Epithelial Cell, donor2	11350-117G9	30.98	2.03	2.90	1.16	0.87	1.16	0.58	0.29	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	23.94	2.49	0.75	0.75	0.75	0.00	0.50	0.00	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	172.20	12.20	38.64	6.78	2.71	0.00	4.07	0.68	4.07	0.68
Mast cell, donor1	11563-120D6	44.01	5.84	9.62	1.30	0.87	0.76	0.87	0.32	1.51	0.22
Mast cell, donor2	11565-120D8	48.14	3.57	3.27	1.19	0.00	0.30	0.30	0.30	0.30	0.89
Mast cell, donor3	11566-120D9	46.83	2.93	5.85	1.58	0.90	0.45	0.68	0.23	1.13	1.13
Mast cell, donor4	11567-120E1	47.34	4.61	5.50	1.77	0.89	0.89	0.18	0.18	0.35	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	60.88	3.88	8.76	0.89	2.44	0.89	0.44	0.44	1.66	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	49.03	6.42	5.84	6.42	0.00	0.00	5.25	0.00	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	54.72	2.87	7.34	0.46	2.06	0.80	0.23	0.11	1.38	0.34
Mast cell, expanded, donor8	11941-126A6	49.21	4.18	9.21	1.51	1.67	0.17	1.34	0.33	1.51	1.17
Melanocyte - dark, donor1	11502-119F8	23.28	3.38	2.59	0.80	0.60	0.40	0.30	0.10	0.50	0.00
Melanocyte - dark, donor2	11582-120F7	19.03	2.77	2.08	1.04	0.69	0.69	0.69	0.35	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	34.84	3.33	4.49	1.81	0.43	1.81	1.01	0.36	0.36	0.36
Melanocyte - light, donor1	11274-116H5	27.50	1.88	2.35	1.41	0.24	0.94	0.24	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	51.18	4.78	0.00	3.41	1.36	0.68	2.73	0.00	1.36	0.00
Melanocyte - light, donor3	11423-118G1	32.09	1.73	1.73	2.60	0.00	0.00	0.87	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	29.36	1.77	2.60	1.56	0.21	0.42	1.35	0.21	0.21	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	27.97	2.69	2.69	2.42	1.61	1.88	0.81	0.27	1.08	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	40.45	3.21	4.02	4.02	0.54	2.95	2.14	0.27	0.54	0.54
Meningeal Cells, donor1	11493-119E8	47.14	4.34	2.73	0.50	1.49	1.12	0.37	0.87	0.25	0.12
Meningeal Cells, donor2	11573-120E7	21.57	2.64	3.08	1.32	1.32	1.76	2.64	0.44	0.88	0.44
Meningeal Cells, donor3	11654-122E7	29.34	3.34	2.20	0.73	0.24	0.82	0.41	0.41	0.41	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	32.79	2.28	1.14	0.29	1.43	0.86	0.86	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	32.30	3.72	2.21	1.91	0.70	0.70	1.31	0.40	1.01	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	103.82	5.26	0.00	1.31	2.63	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	35.32	2.62	0.00	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	25.12	0.00	1.44	0.00	0.00	1.44	1.44	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	24.99	0.85	1.48	0.64	0.42	0.21	0.00	0.21	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	25.63	4.02	0.50	1.01	0.00	0.00	0.50	0.00	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	35.16	3.52	1.32	0.66	0.66	1.10	0.44	0.00	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	33.61	4.38	1.46	0.73	2.19	0.73	0.73	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	30.49	2.66	1.43	1.43	0.82	0.61	0.20	0.41	1.02	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	25.76	1.11	1.25	0.14	1.11	0.83	0.69	0.14	0.28	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	46.84	4.09	0.37	2.60	0.00	0.37	0.00	1.12	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	36.45	2.50	1.32	0.39	1.32	1.45	0.13	0.26	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	34.72	2.37	0.30	1.19	1.19	0.30	0.59	0.00	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	53.72	2.34	4.67	2.34	0.00	0.00	0.00	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	30.74	2.56	1.92	1.92	0.64	0.64	1.92	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	24.10	2.48	1.77	1.06	1.06	0.71	0.35	0.35	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	27.21	1.56	0.63	0.31	0.31	0.63	0.31	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	12.34	2.18	2.18	0.00	0.73	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	29.43	3.98	3.18	3.18	0.80	1.86	0.53	0.27	0.53	0.00
Mesothelial Cells, donor2	12156-128G5	30.03	5.00	1.50	2.00	0.00	0.50	1.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	21.39	3.04	2.02	1.81	0.58	0.43	0.29	0.14	0.65	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	1.35	6.75	0.00	1.35	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	24.63	2.22	8.87	1.72	0.74	0.99	0.00	0.25	0.74	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	19.14	2.06	5.59	1.18	0.29	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	19.53	0.31	3.10	0.93	0.62	0.00	0.31	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	18.25	1.24	1.45	1.04	0.62	0.62	0.41	0.41	0.62	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	26.78	1.25	3.75	0.75	0.00	1.00	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	18.62	1.86	6.05	0.93	0.47	0.93	0.00	0.47	1.40	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	26.62	0.61	3.45	0.41	0.81	0.41	0.00	0.20	0.61	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	22.57	1.19	1.98	1.19	0.79	0.40	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	25.66	1.77	2.65	0.88	0.88	0.88	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	19.00	1.14	3.42	0.38	0.76	1.14	0.38	0.38	1.52	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	3.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	20.59	0.85	3.61	0.64	1.27	0.64	0.21	0.42	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	0.00	3.68	0.00	0.00	0.92	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.60	1.49	2.98	0.00	1.49	0.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	0.00	1.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	16.81	1.51	2.76	0.50	0.25	0.75	0.25	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	11.88	0.95	4.75	0.95	0.00	0.95	0.00	0.48	1.19	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	0.55	2.21	0.00	0.00	0.00	0.55	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	15.66	1.84	2.76	0.23	0.69	1.15	0.46	0.00	1.15	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	15.14	1.05	2.52	0.21	0.21	0.84	0.42	0.21	1.05	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	14.47	1.02	4.48	0.00	0.61	1.63	0.20	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	20.60	1.29	4.29	0.21	0.43	0.86	0.00	0.86	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.45	1.78	4.67	0.22	0.44	0.22	0.44	0.22	0.67	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	12.70	1.53	2.41	0.44	0.22	0.00	0.00	0.44	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.69	0.00	1.01	0.00	0.00	0.00	0.00	0.00	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	1.66	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	13.32	1.63	3.26	0.82	0.00	1.90	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.88	1.18	2.06	0.88	0.00	0.88	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1.09	0.00	0.00	0.00	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	18.74	2.88	2.40	0.48	0.00	0.48	0.48	0.48	1.44	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	17.21	1.20	2.40	0.80	0.40	0.80	0.00	0.40	1.60	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	0.00	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	26.53	2.00	2.50	1.50	0.50	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	18.83	1.75	2.63	0.88	1.31	0.00	0.00	0.00	2.19	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	2.21	4.41	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	6.40	0.64	3.84	0.00	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	19.59	1.24	1.74	1.74	0.50	0.99	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	10.44	0.70	3.48	0.00	0.00	0.00	0.00	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	15.38	1.71	3.42	0.34	0.00	0.34	0.00	0.34	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.31	0.88	2.19	0.00	0.88	0.44	0.00	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.10	0.36	3.20	0.00	0.36	0.00	0.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	22.44	1.12	2.81	0.84	0.84	0.84	0.28	0.00	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	11.64	1.66	1.66	1.25	0.83	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	1.17	1.75	1.75	0.00	0.00	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	13.88	0.90	1.81	0.60	0.30	0.30	0.90	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.53	2.09	3.76	1.25	0.83	0.00	0.83	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	13.85	3.69	4.62	0.00	0.00	1.85	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.94	1.71	2.85	2.28	0.57	0.57	0.57	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	15.20	1.38	3.45	1.11	0.41	0.41	0.14	0.14	0.28	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	18.92	1.81	3.37	0.78	0.78	0.78	0.26	0.26	0.78	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	20.59	1.72	7.72	1.72	0.43	1.72	0.43	0.00	1.29	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.35	0.64	2.54	1.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	17.88	1.33	2.67	0.27	0.27	0.00	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	30.53	1.20	4.19	0.30	0.30	0.90	0.30	0.30	0.90	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.15	0.99	3.67	0.71	0.14	0.28	0.28	0.14	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.98	1.59	3.50	1.27	0.00	0.64	0.64	0.32	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	20.34	1.99	5.53	0.88	1.11	0.44	0.22	0.44	0.66	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.38	2.28	2.28	0.76	1.14	0.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	30.40	2.56	5.97	1.14	0.57	0.85	0.28	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	19.91	1.97	5.16	1.47	0.00	0.74	0.98	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.78	2.61	3.91	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	24.70	2.35	3.82	0.29	0.59	1.18	0.59	0.00	1.18	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.39	2.02	7.50	0.58	0.86	1.44	0.00	0.00	0.86	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.08	5.77	5.77	0.82	1.65	1.24	0.00	0.00	1.24	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	24.42	2.68	3.28	0.00	0.30	0.60	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	48.97	0.00	7.53	0.00	0.00	0.00	3.77	3.77	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	37.43	0.00	1.78	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	38.11	2.63	5.91	0.00	0.66	0.66	0.33	0.66	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	32.61	2.10	1.05	1.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	49.22	1.98	1.98	0.20	0.99	0.20	0.59	0.20	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	29.80	3.73	2.79	0.00	1.86	0.00	0.00	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	34.55	3.00	6.38	1.13	0.75	1.50	0.75	0.38	1.88	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	24.77	0.53	1.60	1.07	0.27	0.00	0.00	0.53	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	24.88	0.79	4.07	0.34	0.90	0.79	0.11	0.11	0.34	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	26.52	0.00	2.95	1.47	0.74	1.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	37.74	3.30	3.66	0.37	1.10	0.00	0.37	0.00	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	32.67	1.56	6.22	0.00	0.00	0.00	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	21.91	1.07	3.21	0.53	0.53	1.60	0.53	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	0.00	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	42.42	6.06	3.03	2.02	1.01	0.00	1.01	2.02	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	23.61	1.69	3.37	0.42	0.84	0.84	0.42	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	14.98	1.36	1.36	1.36	0.00	2.72	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	11.44	0.64	1.91	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.15	0.00	4.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	0.00	3.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	39.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	0.00	3.26	0.00	3.26	0.00	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	0.00	0.00	4.75	4.75	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	22.19	2.59	1.51	0.86	0.65	0.43	0.43	0.86	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	27.70	1.57	0.52	5.23	1.05	1.57	1.57	0.00	0.00	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	22.69	2.67	0.67	1.33	0.00	0.67	1.33	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.43	0.83	0.42	1.25	0.42	0.42	0.42	0.00	1.25	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	25.86	1.71	3.23	1.14	1.14	0.76	0.95	0.38	0.19	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	0.00	6.38	0.00	0.00	3.19	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	0.68	0.00	0.00	0.00	0.00	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	0.00	1.84	0.00	0.00	1.84	0.00	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	14.23	4.60	2.51	1.26	0.00	0.84	0.84	0.00	0.42	2.09
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	20.22	1.63	1.63	1.16	0.93	1.16	0.00	0.46	0.70	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.08	2.43	0.27	2.16	0.00	0.00	1.35	0.00	0.81	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	28.59	2.52	1.26	1.89	0.42	0.63	0.42	0.21	0.42	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	25.31	3.97	0.00	1.99	0.00	1.49	0.99	0.00	0.50	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	23.82	0.81	0.81	2.71	0.27	1.08	1.08	0.54	0.54	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	19.72	1.36	0.68	2.04	0.68	0.68	0.23	0.00	0.91	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.66	4.08	1.14	0.98	0.49	0.16	0.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	29.53	3.83	1.46	2.19	0.00	0.91	0.73	0.00	0.36	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.97	2.65	1.06	1.59	0.53	1.59	1.06	0.00	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.21	2.40	1.80	1.80	0.00	0.00	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	31.50	2.95	2.30	3.61	0.66	1.31	0.33	1.97	0.66	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	13.99	3.09	0.65	0.98	0.33	1.30	0.49	0.00	0.49	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	27.34	5.12	1.76	2.65	0.35	1.06	0.71	0.18	0.88	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	21.10	2.11	0.70	2.81	0.00	0.00	1.41	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	21.61	4.14	0.00	1.38	0.46	0.92	0.92	0.00	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	22.82	6.75	2.25	4.82	0.32	0.64	0.96	0.00	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	24.83	2.07	2.07	0.34	0.00	0.69	1.72	0.69	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	78.38	7.59	2.53	2.53	0.00	7.59	0.00	5.06	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	26.73	3.56	2.67	2.67	1.11	0.45	0.45	0.67	0.89	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	23.71	2.96	0.42	1.69	0.42	0.00	1.27	0.42	0.85	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.99	4.03	0.71	1.66	0.47	0.47	0.47	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	25.75	3.86	0.86	2.15	0.43	0.00	1.29	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	0.00	9.03	0.00	9.03	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	25.66	5.00	0.00	4.67	0.00	0.67	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	17.58	2.71	1.35	2.71	0.00	0.90	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.08	4.36	1.59	2.38	0.40	0.00	0.40	0.40	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	0.00	0.93	1.86	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	37.46	4.16	0.76	5.30	0.76	0.76	1.14	0.38	0.00	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.04	3.58	1.63	1.96	0.65	0.65	0.65	0.00	0.65	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	14.82	2.61	1.74	0.87	0.44	0.87	0.87	0.00	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	24.88	5.43	3.62	2.26	0.00	0.45	1.36	0.00	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	15.87	5.29	0.88	1.76	0.00	0.00	0.88	0.00	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.95	1.99	1.33	1.33	0.00	0.00	1.33	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	24.31	3.47	2.98	2.48	0.00	0.00	0.00	0.00	0.00	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	22.59	1.91	2.30	1.53	0.00	0.00	0.77	0.00	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	64.72	7.26	2.42	7.86	1.21	0.30	1.81	0.30	1.51	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	25.20	3.09	2.65	1.99	0.66	0.44	1.33	1.11	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	21.01	2.71	1.36	1.36	0.68	0.68	0.00	0.00	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	10.22	5.11	0.00	0.00	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.73	3.05	2.44	3.66	1.22	1.22	0.00	0.00	0.61	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	24.55	2.52	1.57	0.94	0.00	0.31	1.57	0.00	0.94	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	20.88	4.84	0.61	2.42	0.30	0.61	1.21	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	34.81	2.37	2.37	2.37	0.79	0.79	1.58	0.79	1.58	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	28.34	0.00	3.40	2.27	0.00	1.13	2.27	3.40	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	0.00	10.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	19.38	2.73	1.86	0.62	0.25	1.24	0.50	0.12	0.75	0.00
Myoblast, donor2	11322-117D8	27.43	2.69	2.69	0.96	0.96	0.19	0.38	0.19	0.96	0.19
Myoblast, donor3	11398-118D3	28.92	3.87	4.04	0.67	0.67	2.02	0.34	0.17	0.50	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	38.82	2.92	3.79	0.73	0.44	0.58	0.44	0.15	0.58	0.29
Natural Killer Cells, donor1	11230-116C6	127.62	7.69	4.61	2.15	3.38	1.54	0.62	0.62	0.62	0.62
Natural Killer Cells, donor2	11311-117C6	109.77	11.16	3.92	4.82	3.02	2.11	1.51	0.30	0.30	1.51
Natural Killer Cells, donor3	11387-118C1	96.81	8.65	2.21	4.60	2.21	2.39	1.10	0.00	0.18	1.29
Neural stem cells, donor1	11275-116H6	72.59	11.61	5.44	9.07	0.00	2.90	3.99	0.73	2.54	0.73
Neural stem cells, donor2	11352-117H2	75.10	21.18	1.93	5.78	0.00	1.93	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	55.76	13.65	0.00	4.55	0.00	0.00	5.69	1.14	0.00	0.00
Neurons, donor2	11574-120E8	62.09	11.45	2.20	3.74	0.66	0.88	2.20	0.88	0.00	0.00
Neurons, donor3	11655-122E8	73.99	11.51	0.00	12.33	0.00	0.82	4.11	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	22.27	0.93	0.00	1.86	0.93	0.00	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	2.90	0.00	2.90	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	23.82	0.00	0.61	1.22	0.61	0.61	0.00	0.61	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	26.60	4.39	0.24	1.54	0.71	0.00	1.07	0.47	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	26.37	2.93	0.65	1.30	0.33	0.33	0.98	0.65	1.30	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	18.05	2.61	0.80	0.40	0.00	0.20	0.80	0.20	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	21.61	3.99	1.10	4.27	0.00	0.55	1.51	0.28	0.28	0.00
Olfactory epithelial cells, donor2	11934-125I8	29.82	4.49	0.87	3.76	0.58	0.43	1.59	0.00	0.29	0.29
Olfactory epithelial cells, donor3	11935-125I9	28.94	6.47	0.68	3.41	0.23	0.45	1.02	0.23	0.23	0.23
Olfactory epithelial cells, donor4	11936-126A1	25.03	5.16	0.39	2.14	0.10	0.29	0.58	0.19	0.10	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	27.08	3.01	4.81	0.00	1.20	1.20	1.20	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	30.42	2.55	1.49	1.49	0.85	0.00	0.85	0.43	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	42.30	3.43	0.00	1.14	0.00	0.00	0.00	0.00	0.00	3.43
Osteoblast - differentiated, donor3	11425-118G3	37.86	9.31	1.86	4.34	1.24	0.00	0.00	0.00	0.00	3.10
Osteoblast, donor1	11277-116H8	61.76	7.23	1.17	2.54	1.95	0.00	0.59	0.98	0.39	0.39
Osteoblast, donor2	11354-117H4	28.09	2.81	1.40	1.40	1.40	0.00	0.70	1.40	0.70	0.00
Osteoblast, donor3	11426-118G4	23.46	3.91	1.24	1.42	0.89	0.00	0.89	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	29.82	2.86	1.60	1.01	1.01	0.25	0.51	0.34	0.25	0.17
Pericytes, donor1	11491-119E6	35.16	2.23	0.45	1.89	1.11	0.45	0.45	0.00	0.45	0.56
Pericytes, donor2	11571-120E5	25.13	1.81	1.36	2.04	0.23	0.00	1.58	0.45	0.68	0.00
Pericytes, donor3	11652-122E5	21.57	2.64	1.02	1.22	0.61	0.41	1.02	0.41	0.20	0.00
Perineurial Cells, donor1	11499-119F5	27.01	2.94	1.13	0.79	0.23	0.34	0.23	0.11	0.45	0.00
Perineurial Cells, donor2	11579-120F4	33.68	2.85	3.96	0.74	1.47	1.38	0.46	0.74	0.74	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	89.88	5.10	6.06	2.87	0.96	0.64	0.64	0.32	0.64	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	57.79	3.43	2.69	1.47	0.98	0.00	0.24	0.24	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	57.72	4.27	2.98	2.07	1.42	0.39	0.78	0.52	0.78	0.65
Placental Epithelial Cells, donor1	11278-116H9	64.10	2.15	1.91	2.15	3.35	0.96	0.48	0.48	0.24	0.72
Placental Epithelial Cells, donor2	11355-117H5	67.64	4.44	3.33	4.44	0.00	1.11	2.22	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	39.66	4.71	1.18	1.96	1.18	0.59	1.57	0.20	0.20	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	11.39	2.22	1.58	0.95	0.00	0.32	0.32	0.00	0.00	0.95
Preadipocyte - breast, donor1	11467-119B9	32.08	5.82	1.31	3.38	1.50	0.19	1.50	0.00	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	72.96	10.31	3.52	4.57	2.09	0.13	1.17	0.26	0.39	0.00
Preadipocyte - breast, donor2	11328-117E5	28.14	4.50	1.13	2.03	0.23	0.23	0.23	0.23	0.68	0.23
Preadipocyte - omental, donor1	11468-119C1	40.17	5.43	1.92	3.09	0.96	0.53	1.28	0.53	0.53	0.75
Preadipocyte - omental, donor2	11329-117E6	34.92	4.80	3.49	1.31	1.31	2.18	1.31	0.44	1.31	0.44
Preadipocyte - omental, donor3	11403-118D8	28.94	5.01	2.15	3.44	0.57	1.00	0.86	0.43	0.43	0.86
Preadipocyte - perirenal, donor1	11469-119C2	10.83	1.97	2.95	1.97	0.00	0.98	2.95	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	44.22	6.14	1.23	2.15	1.23	0.00	1.23	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	26.21	2.66	1.42	1.42	1.06	0.71	0.53	0.53	0.35	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	19.92	3.41	0.68	2.04	0.51	1.02	0.85	0.17	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	35.21	4.75	2.05	1.96	0.93	1.12	1.40	0.09	0.47	0.37
Preadipocyte - visceral, donor2	11357-117H7	20.71	5.06	0.46	2.30	0.46	0.46	0.00	0.00	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	19.02	2.09	1.15	0.63	0.21	0.94	0.42	0.21	0.84	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	43.45	3.17	4.98	2.11	2.11	1.81	0.60	1.66	0.60	0.75
Prostate Epithelial Cells, donor2	11331-117E8	18.96	2.30	1.90	1.76	0.95	1.22	0.41	0.14	0.14	0.54
Prostate Epithelial Cells, donor3	11404-118D9	23.09	1.16	0.61	0.61	1.47	0.43	0.37	0.24	0.12	0.37
Prostate Stromal Cells, donor1	11254-116F3	29.39	2.62	2.39	1.59	1.25	0.57	0.46	0.34	0.57	0.34
Prostate Stromal Cells, donor2	11332-117E9	23.49	3.59	0.90	1.26	0.54	1.43	0.54	0.90	0.36	0.18
Prostate Stromal Cells, donor3	11405-118E1	22.11	2.19	1.04	0.94	0.42	1.25	0.83	0.10	0.21	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	29.20	0.73	1.09	0.36	0.00	0.00	0.36	0.36	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	22.73	2.22	0.35	0.62	0.21	0.07	0.62	0.21	0.14	0.00
Renal Epithelial Cells, donor1	11517-119H5	55.80	4.06	0.00	1.52	0.00	0.51	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	22.76	2.13	0.71	2.13	1.42	0.71	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	29.43	2.75	0.74	1.59	0.53	0.32	0.74	0.85	0.21	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	21.11	4.09	0.00	0.00	0.68	1.36	1.36	0.68	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	21.43	1.62	1.89	1.21	0.94	0.67	0.00	0.27	0.67	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	19.09	2.66	2.22	0.44	0.44	0.89	0.44	0.44	0.44	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	31.94	3.99	3.33	2.00	0.00	2.00	0.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	33.67	3.08	0.00	0.88	0.66	0.00	1.10	0.88	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	30.72	4.39	0.63	1.25	1.88	0.00	0.00	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	31.07	3.33	0.28	1.11	0.83	0.55	0.83	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	25.77	5.10	0.00	1.07	1.07	0.27	0.54	0.27	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	20.66	0.84	0.00	1.69	0.42	0.00	1.27	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	35.10	3.47	0.39	2.31	0.58	0.39	0.39	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	20.74	2.07	2.07	0.00	0.26	0.78	0.26	0.26	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	39.23	2.56	1.71	0.57	1.14	0.28	0.85	0.85	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	26.76	3.09	1.03	1.03	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	44.91	6.52	0.75	2.01	0.75	1.00	1.00	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	41.03	3.34	4.68	1.34	1.07	0.40	0.67	0.67	0.13	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	67.90	8.04	5.36	2.68	1.79	0.00	2.68	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	101.82	5.50	16.51	0.55	1.10	1.10	3.30	1.65	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	64.39	3.48	11.60	0.58	0.58	0.58	1.16	0.00	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	41.61	4.42	7.80	1.30	1.95	1.17	0.78	0.00	0.78	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	35.45	3.87	6.45	0.99	1.49	1.19	0.50	0.30	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	56.44	4.68	8.48	1.67	1.67	1.90	0.78	1.12	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	46.52	4.09	9.68	2.23	1.12	2.60	0.99	0.62	0.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	42.89	3.50	6.41	1.40	1.63	1.75	0.82	0.23	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	49.23	6.24	12.71	2.31	1.39	2.54	2.08	0.46	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	38.33	3.83	7.12	1.37	1.51	1.64	0.41	0.96	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	40.09	4.84	8.02	2.12	1.06	1.97	0.30	0.45	0.30	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	43.01	3.94	7.35	2.51	1.79	1.08	0.72	0.54	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	37.44	3.73	6.74	1.86	1.72	1.72	0.29	0.86	0.14	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	42.71	3.54	6.55	0.75	1.07	1.72	0.21	0.32	0.43	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	48.90	4.20	7.97	1.33	1.33	2.21	0.66	0.44	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	33.07	4.01	6.31	1.34	2.10	1.15	1.15	0.38	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	39.59	3.82	6.80	1.12	1.40	1.49	0.84	0.28	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	60.88	6.95	9.40	2.25	3.01	1.88	1.13	0.75	1.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	34.64	3.32	7.83	2.26	1.73	1.06	0.80	0.00	1.06	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	49.64	4.38	7.20	1.46	1.17	0.97	0.97	0.68	0.68	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	47.17	4.58	7.07	1.15	1.34	1.53	0.76	1.34	0.76	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	34.07	4.59	7.69	1.71	1.60	1.60	0.96	0.53	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	37.28	3.92	5.33	1.68	1.68	0.84	0.84	0.00	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	40.67	5.98	6.67	2.05	1.20	1.37	0.68	0.51	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	31.00	3.65	5.11	1.64	1.46	1.28	0.55	0.18	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	41.94	3.92	7.97	1.84	2.82	1.96	0.37	0.37	0.74	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	42.31	3.90	6.45	1.61	2.28	1.21	0.54	0.67	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	38.45	4.95	8.26	0.71	3.07	1.65	0.00	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	43.85	3.77	7.94	2.58	1.79	2.18	0.60	1.19	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	48.64	4.68	8.65	1.87	1.40	1.64	0.94	0.47	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	36.49	3.73	4.56	1.66	2.70	1.04	0.41	1.66	0.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	36.94	3.32	7.08	0.66	1.55	1.33	0.44	0.88	1.11	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	38.43	4.80	4.60	1.46	0.84	2.51	0.42	0.84	0.63	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	48.45	3.63	6.33	1.88	2.83	2.42	0.54	0.54	1.62	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	42.06	4.26	6.81	1.87	2.21	1.87	0.68	0.51	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	44.92	4.24	6.94	1.54	0.96	1.16	1.16	0.39	0.77	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	56.74	6.19	7.74	1.72	1.38	2.58	0.52	1.03	1.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	44.72	4.80	8.78	1.51	1.92	2.88	0.82	0.14	0.55	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	50.89	5.75	12.81	2.46	2.46	3.94	0.16	0.66	0.82	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	41.93	3.58	11.76	2.22	1.87	2.39	0.17	0.68	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	49.71	4.14	9.62	1.92	1.48	2.22	2.07	0.44	0.74	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	58.91	6.93	10.93	1.87	1.87	2.67	0.53	0.27	1.33	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	47.15	5.95	8.99	3.18	1.66	1.38	1.66	0.14	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	49.29	6.90	7.86	1.43	2.14	0.95	0.71	0.71	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	71.14	6.65	13.70	3.22	3.02	2.62	1.41	0.40	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	44.83	5.74	7.82	2.07	2.45	1.22	0.75	0.38	0.57	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	73.02	7.69	8.73	2.45	1.75	1.75	1.75	0.70	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	69.51	4.84	8.76	3.63	2.42	2.42	1.51	0.60	1.51	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	50.30	6.00	10.89	1.96	1.59	1.22	1.22	0.49	0.98	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	106.11	11.21	10.04	3.64	1.89	2.47	2.04	1.46	0.87	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	73.01	6.69	10.95	1.83	3.04	3.04	1.83	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	52.14	5.43	6.93	2.41	2.11	0.90	1.81	0.00	0.00	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	77.58	7.69	10.18	2.04	2.49	1.81	1.36	0.45	0.90	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	94.36	6.29	8.39	3.00	2.10	0.90	0.30	0.30	0.60	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	68.84	6.73	9.92	3.90	2.36	1.06	1.18	1.18	0.71	4.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	65.95	6.62	8.75	1.07	1.28	1.71	0.64	0.64	0.21	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	75.12	4.81	12.02	0.60	1.20	3.61	0.00	1.20	1.20	0.60
Schwann Cells, donor1	11498-119F4	33.10	3.76	0.19	0.75	0.19	0.38	0.38	0.00	0.56	0.00
Schwann Cells, donor2	11578-120F3	30.62	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	21.47	2.19	0.88	1.31	0.66	0.44	0.22	0.00	0.66	0.00
Sebocyte, donor1	11220-116B5	60.80	6.03	6.57	3.83	0.00	2.19	2.19	0.55	1.10	1.10
Sebocyte, donor2	11301-117B5	37.68	2.76	3.68	5.06	0.00	1.84	0.46	0.00	0.46	0.92
Sebocyte, donor3	11378-118B1	31.33	4.95	2.27	2.06	0.62	1.86	0.21	0.21	0.62	0.62
Sertoli Cells, donor1	11255-116F4	39.76	0.00	1.66	3.31	0.00	0.00	1.66	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	39.54	5.65	0.00	2.82	0.00	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	43.11	6.60	1.32	2.20	0.70	0.62	0.97	0.18	0.44	0.26
Skeletal Muscle Cells, donor2	11358-117H8	67.95	20.24	2.17	3.61	0.72	0.00	1.45	0.00	1.45	1.45
Skeletal Muscle Cells, donor3	11430-118G8	66.88	4.18	0.84	1.67	0.84	0.84	0.84	0.84	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	19.64	2.04	1.10	1.26	0.94	0.94	0.47	0.63	0.63	0.31
Skeletal Muscle Cells, donor5	11455-119A6	23.93	3.57	0.89	1.19	0.59	1.49	0.45	0.30	0.74	0.00
Skeletal Muscle Cells, donor6	11459-119B1	24.93	2.00	2.46	0.77	0.62	0.77	0.92	0.15	0.46	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	41.08	3.91	2.77	1.13	1.13	1.76	1.76	0.25	0.38	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	33.82	2.85	1.14	1.28	0.57	1.00	0.57	0.43	0.29	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	29.37	3.47	1.59	1.19	1.29	0.89	0.60	0.60	0.30	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	37.49	6.23	3.45	1.94	0.93	0.84	1.18	0.34	0.59	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	51.39	9.41	1.45	4.34	0.72	0.00	1.45	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	21.19	2.89	0.41	0.69	0.41	0.28	0.28	0.00	0.55	0.41
Skin - palm, donor1	10286-104F7	8.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	10.24	1.01	0.43	0.86	0.86	0.29	0.29	0.29	0.00	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	161.12	8.18	2.45	17.18	3.27	2.45	4.09	2.45	2.45	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	11.68	1.04	0.65	1.04	0.13	0.00	0.65	0.26	0.26	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	30.44	4.03	1.67	1.95	0.28	0.28	0.14	0.42	0.70	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	18.71	1.83	1.27	1.69	0.42	0.84	0.42	0.00	0.42	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	179.94	16.49	2.33	8.67	4.86	2.11	1.48	3.38	1.06	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	22.71	2.25	0.37	1.27	1.05	0.22	0.30	0.07	0.45	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	17.28	1.54	0.31	0.93	0.31	0.31	0.62	0.93	0.31	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	32.02	5.34	1.78	4.67	0.67	0.44	1.11	0.89	1.56	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	38.80	5.88	0.59	1.76	0.59	0.59	0.59	0.59	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	30.72	4.20	0.44	0.88	0.44	0.44	0.66	0.22	0.22	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	23.63	3.15	1.18	0.39	0.39	0.79	0.39	0.79	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	46.35	10.04	1.55	1.55	3.09	0.77	2.32	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	42.03	7.01	2.00	1.00	1.00	1.00	2.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	23.42	2.13	0.40	0.40	0.27	0.00	0.40	0.27	0.40	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	23.05	3.77	1.11	1.11	0.00	0.44	0.89	0.00	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	16.64	1.28	1.02	1.15	0.90	0.51	0.38	0.13	0.51	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	29.63	2.60	2.28	0.33	1.63	0.98	0.00	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	33.37	3.84	2.36	0.89	0.59	1.18	1.77	0.30	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	17.23	2.28	1.57	1.57	0.14	0.85	0.43	0.00	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	24.73	1.79	0.98	0.16	0.81	0.33	0.16	0.33	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	24.05	2.74	0.30	0.61	0.91	0.00	0.30	0.61	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	53.29	6.31	0.51	1.52	1.01	0.25	1.77	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	6.12	0.00	6.12	0.00	0.00	0.00	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	29.56	6.20	0.95	0.00	0.00	0.00	0.95	0.95	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	28.46	2.36	1.33	0.88	0.44	1.03	0.15	0.59	0.44	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.66	2.58	1.51	0.65	0.00	1.29	0.65	0.43	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	23.51	2.83	1.47	0.52	0.52	0.63	0.52	0.21	0.84	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	28.15	4.02	2.17	1.08	0.77	0.31	0.46	0.15	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	19.40	4.31	0.00	1.08	0.00	2.16	0.00	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	13.75	3.59	2.09	1.20	0.90	0.30	0.60	0.00	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	31.75	4.44	1.37	0.68	1.37	0.00	0.00	0.00	1.02	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	38.24	3.69	1.49	1.26	0.63	0.55	0.31	0.16	0.16	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	21.34	1.91	1.41	1.11	1.21	0.30	1.01	0.20	0.81	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	30.04	5.46	1.59	3.19	0.46	1.14	0.68	0.23	0.91	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	20.53	4.83	1.21	0.00	0.60	0.00	1.21	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	33.12	2.65	2.38	0.53	0.26	1.06	0.53	0.53	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	27.03	2.00	1.46	0.27	1.07	0.27	1.33	0.27	0.80	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	25.54	3.38	2.75	1.38	0.63	0.38	0.50	0.50	1.25	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	23.84	3.55	0.00	0.25	0.76	0.76	0.51	0.25	0.76	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	28.19	2.86	0.90	1.21	0.90	0.30	0.30	0.30	0.15	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	24.76	2.25	0.00	0.00	0.00	0.00	3.00	0.00	0.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	15.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	47.44	8.37	0.93	1.86	1.40	0.93	0.47	0.00	1.40	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	30.29	3.03	0.50	2.52	1.01	1.01	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	16.61	2.82	1.25	0.94	0.00	1.25	0.63	0.31	0.63	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	20.35	1.47	0.59	0.59	0.59	0.59	0.29	0.29	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	33.32	2.83	1.75	0.67	1.08	0.50	0.25	0.42	1.17	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	34.57	3.27	0.93	0.93	0.00	0.47	1.40	0.47	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	21.59	2.30	0.72	0.86	1.44	0.14	0.43	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	29.06	3.06	1.27	1.53	0.76	0.00	0.25	0.25	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	19.37	3.20	0.38	1.69	0.38	0.38	0.38	0.19	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	33.26	4.75	3.07	0.84	0.42	0.84	0.56	0.14	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	23.80	2.09	1.34	0.42	0.34	0.34	0.42	0.17	0.34	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	21.90	1.43	1.43	0.95	0.95	0.48	0.48	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	21.53	0.98	0.24	0.24	0.73	0.24	0.00	0.00	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	22.09	2.21	0.66	1.10	0.22	0.22	0.22	0.22	0.44	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	35.69	3.22	1.76	0.88	1.17	1.17	0.29	0.59	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	35.57	7.00	0.97	2.92	0.00	0.58	1.36	0.00	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	28.30	3.97	1.06	1.59	0.00	0.00	0.26	0.53	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	32.36	2.60	1.12	0.74	0.37	0.74	0.00	0.74	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	25.87	3.59	1.44	1.08	0.36	0.72	1.44	0.72	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	18.17	2.84	0.57	1.42	0.00	0.00	0.00	0.57	0.28	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	33.08	3.54	3.94	3.15	1.18	0.79	0.79	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	25.40	2.54	1.52	1.78	0.00	0.51	0.51	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	23.16	3.19	0.80	2.00	0.00	0.00	0.00	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	27.17	3.76	0.84	1.25	0.42	0.84	0.42	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	40.34	5.04	1.38	2.29	0.00	1.38	1.38	0.00	0.92	0.92
Synoviocyte, donor1	11291-117A4	21.04	3.87	1.18	1.68	0.67	1.01	0.34	0.34	0.17	0.50
Synoviocyte, donor2	11368-117I9	22.63	4.02	1.34	3.18	0.50	1.01	0.84	0.17	0.17	0.34
Synoviocyte, donor3	11440-118H9	20.33	1.56	1.34	1.12	0.22	1.12	0.45	0.22	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	41.45	5.00	1.79	1.79	0.71	0.71	1.07	0.71	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	39.64	1.98	1.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	38.44	3.70	1.39	1.85	0.93	0.93	1.85	0.46	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	23.80	3.08	0.93	1.15	0.72	0.36	0.50	0.29	0.07	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	35.18	4.64	0.77	1.93	0.39	0.77	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	38.94	6.30	1.15	2.29	1.15	0.57	0.00	0.57	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	43.92	1.85	3.32	1.23	0.98	1.60	0.49	0.12	0.62	0.49
Urethra, donor2	10319-105A4	17.98	3.60	0.00	0.00	0.00	0.00	0.00	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	23.38	2.13	1.59	2.39	0.27	0.00	1.33	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	30.44	3.20	0.80	0.40	0.40	0.00	0.40	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	20.86	1.83	0.92	0.69	0.92	0.23	0.46	0.00	0.23	0.23
Urothelial cells, donor0	11216-116B1	27.19	0.89	2.01	0.67	0.22	0.45	0.45	0.00	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	73.85	2.67	0.89	1.78	0.00	0.00	0.00	0.89	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	50.04	0.00	7.15	2.86	1.43	0.00	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	34.23	1.37	0.68	0.00	1.37	0.00	0.68	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	64.39	3.79	2.75	0.34	0.34	0.00	0.34	0.34	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	76.11	2.32	1.74	0.00	1.74	0.00	0.00	1.16	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	57.27	1.04	2.08	2.08	2.08	0.00	0.00	2.08	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	49.56	0.00	2.75	0.00	2.75	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	42.91	0.00	0.00	0.91	1.83	0.00	0.00	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	47.00	6.41	6.91	1.36	1.73	1.36	0.99	0.37	1.11	0.25
Wilms' tumor cell line:HFWT	10597-108E3	26.40	6.16	4.40	1.76	0.88	0.00	1.76	0.00	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	75.42	6.98	3.35	1.40	4.19	0.56	3.07	0.84	1.12	0.00
achilles tendon, donor2	10292-104G4	14.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	43.09	7.90	1.78	1.27	0.76	0.25	1.78	0.51	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	53.40	9.52	0.70	3.25	1.39	0.00	2.79	0.46	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	70.04	8.31	5.94	2.97	2.37	0.83	0.95	0.12	0.47	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	51.16	4.90	8.98	1.36	1.36	1.63	0.27	0.54	1.36	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	36.54	3.65	6.75	0.56	1.69	1.97	0.28	0.00	0.84	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	62.39	5.71	12.05	1.48	5.50	1.90	2.11	0.21	0.63	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	45.19	6.26	12.25	0.82	0.54	2.72	0.82	1.36	1.91	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	23.79	2.20	11.02	0.00	0.44	0.44	0.00	0.44	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	35.94	4.08	11.43	0.82	1.23	1.63	0.82	0.82	1.23	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	27.57	1.55	7.77	1.16	1.55	2.33	0.39	0.00	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	34.59	1.10	2.94	0.18	2.58	0.55	0.74	0.74	0.74	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	3.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	34.62	3.72	12.32	0.46	0.23	3.72	0.93	0.00	1.86	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	42.72	3.62	7.77	0.52	2.33	1.04	0.26	0.26	1.81	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	33.90	2.63	3.80	2.34	1.75	0.88	0.00	0.58	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	30.21	0.46	2.32	0.00	1.39	0.93	0.46	0.00	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	43.18	1.23	3.70	0.41	3.70	0.41	0.00	0.41	1.23	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	9.82	0.31	2.15	0.00	0.31	0.61	0.00	0.31	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	30.30	1.71	9.81	0.00	2.13	0.00	0.00	0.43	1.28	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	27.30	1.82	11.22	0.30	1.82	0.91	0.00	0.30	2.12	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	36.83	1.44	10.11	0.48	2.65	0.96	0.24	0.24	2.17	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	45.44	0.89	7.13	0.45	3.12	2.23	0.22	0.45	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	29.02	2.00	5.00	0.00	0.67	1.67	0.33	1.33	1.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	39.02	1.86	7.43	1.86	0.00	3.72	3.72	0.00	5.57	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	47.84	6.03	9.42	1.13	1.13	3.01	0.38	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	34.45	6.98	14.83	2.18	0.44	3.49	2.18	0.87	0.87	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	26.24	13.12	11.25	9.37	1.87	1.87	0.00	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	39.33	2.83	8.24	1.18	1.18	1.41	1.18	0.00	0.47	0.24
adipose tissue, adult, pool1	10010-101C1	28.54	2.17	1.71	1.71	0.47	0.62	0.78	0.16	0.31	0.47
adipose, donor1	10184-103D4	69.20	5.86	7.04	3.52	1.17	0.59	2.35	1.76	0.59	12.90
adipose, donor2	10185-103D5	57.58	10.14	1.62	2.84	0.41	0.81	0.41	0.00	0.00	15.00
adipose, donor3	10186-103D6	54.46	5.99	3.00	3.27	1.63	0.27	1.91	2.18	0.54	9.26
adipose, donor4	10187-103D7	27.74	3.47	0.87	1.73	0.87	0.87	1.73	0.00	0.87	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	34.88	3.47	6.15	1.10	2.05	0.32	0.95	0.63	1.89	0.32
adrenal gland, adult, pool1	10081-102A9	36.38	0.00	3.64	0.00	0.00	0.00	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	63.37	5.07	9.21	1.07	1.47	1.20	1.07	0.80	0.93	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	52.88	5.00	4.64	2.14	1.79	0.36	1.07	0.36	1.07	0.00
amniotic membrane cells, donor1	12235-129G3	21.10	1.16	2.78	1.62	0.93	0.93	0.70	0.00	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	47.67	0.68	1.35	1.01	0.68	0.34	0.00	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	14.73	0.29	1.77	0.59	0.88	0.29	0.29	0.29	0.88	0.29
amygdala - adult, donor10196	10167-103B5	62.85	8.30	14.23	9.49	0.00	1.19	5.93	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	49.07	7.91	5.88	2.43	0.81	0.61	1.82	0.41	1.01	0.20
amygdala, newborn, donor10223	10360-105E9	35.18	8.07	3.23	8.71	0.65	0.97	0.65	0.32	0.97	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	94.99	12.35	0.25	2.55	1.66	0.00	2.80	1.15	0.13	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	35.08	3.97	6.18	3.31	1.76	1.10	0.22	0.22	1.32	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	59.79	15.70	0.33	5.34	0.33	0.00	5.01	0.67	0.00	0.67
aorta, adult, pool1	10052-101G7	30.79	3.92	1.77	1.37	0.20	0.00	1.18	0.39	0.20	0.20
appendix, adult	10189-103D9	58.61	3.49	2.72	1.55	0.39	0.00	0.78	0.00	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	59.50	4.82	3.44	2.41	1.03	1.03	2.06	1.38	0.34	0.00
artery, adult	10190-103E1	35.33	2.72	1.36	0.00	2.72	1.36	0.00	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	78.23	3.48	7.68	4.78	1.88	1.30	1.16	0.29	0.43	0.87
b cell line:RPMI1788	10427-106D4	48.33	4.16	1.34	0.74	1.19	0.15	0.45	0.45	0.15	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	23.58	2.77	1.94	0.28	0.28	0.55	0.83	0.83	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	35.13	2.98	2.88	0.69	2.08	0.50	0.50	0.50	0.60	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	57.08	4.02	3.85	0.84	2.51	0.84	0.00	0.33	0.84	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	25.17	0.00	2.80	1.68	0.56	0.00	0.56	0.56	1.68	0.00
bladder, adult, pool1	10011-101C2	31.18	3.04	1.30	1.09	0.33	0.54	0.43	0.11	0.43	0.33
blood, adult, pool1	10053-101G8	19.93	4.43	6.64	0.00	2.21	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	23.98	2.57	0.00	0.86	0.86	0.86	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	39.14	3.37	1.35	2.70	0.67	2.70	0.67	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	53.30	14.35	3.08	3.08	0.00	0.00	2.05	0.00	3.08	2.05
brain, adult, pool1	10012-101C3	55.12	12.69	6.79	5.01	0.33	1.67	2.12	0.33	1.22	0.67
brain, fetal, pool1	10085-102B4	77.47	16.03	2.67	13.36	0.00	0.00	5.34	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	27.09	1.65	4.96	0.66	0.66	0.33	0.33	0.33	0.99	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	56.67	6.12	14.23	5.12	1.87	5.49	1.25	0.12	1.37	0.12
breast, adult, donor1	10080-102A8	35.36	3.16	1.26	1.26	0.00	0.63	1.26	0.00	0.00	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	24.01	1.02	3.30	0.13	2.79	0.38	0.25	0.13	1.02	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	42.67	5.57	3.09	2.47	2.16	2.16	1.86	0.62	1.86	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	69.07	5.99	4.60	0.92	2.53	0.92	0.69	0.69	1.61	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	29.78	1.69	5.33	1.21	1.94	1.45	0.48	0.48	1.45	0.24
carcinoid cell line:NCI-H1770	10703-109H1	55.95	3.29	2.35	0.47	0.00	0.47	0.00	0.47	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	43.97	2.84	1.64	0.55	1.75	0.11	0.98	1.09	0.88	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	44.05	6.02	1.58	1.90	0.00	0.32	0.63	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	78.52	14.37	1.33	6.65	1.06	1.86	3.19	0.27	0.53	1.33
caudate nucleus - adult, donor10196	10177-103C6	78.29	12.66	11.51	0.00	1.15	3.45	3.45	0.00	4.61	0.00
caudate nucleus, adult, donor10252	10164-103B2	56.39	7.03	9.54	1.84	0.50	1.17	1.00	0.67	0.67	0.00
caudate nucleus, adult, donor10258	10379-105H1	59.60	9.17	6.11	6.11	0.00	0.76	0.00	2.29	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	49.44	8.06	5.49	2.20	1.10	1.83	0.37	0.73	1.10	0.73
cerebellum - adult, donor10196	10173-103C2	134.01	11.65	23.31	5.83	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	92.45	7.69	9.18	5.98	2.14	1.07	1.92	0.85	1.07	0.00
cerebellum, adult, pool1	10083-102B2	56.92	7.93	3.10	4.83	0.00	0.69	1.03	0.00	1.72	0.34
cerebellum, newborn, donor10223	10357-105E6	137.83	16.61	4.98	20.76	4.15	5.81	4.15	0.00	3.32	0.00
cerebral meninges, adult	10188-103D8	37.82	6.30	6.30	4.79	0.50	2.02	1.26	0.25	1.76	0.76
cerebrospinal fluid, donor2	10294-104G6	16.08	0.73	0.73	2.19	0.00	0.73	0.73	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	94.90	6.90	18.98	2.73	3.88	9.06	2.59	0.58	3.16	0.72
cervical cancer cell line:ME-180	10553-107I4	74.08	5.63	2.98	3.31	1.99	0.99	0.66	1.33	0.33	0.00
cervix, adult, pool1	10013-101C4	49.24	5.46	1.05	1.78	0.63	0.42	1.47	0.10	0.00	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	41.24	6.83	4.74	3.07	0.42	1.39	0.98	0.14	0.56	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	10.45	2.61	2.61	0.00	1.31	0.00	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	42.01	3.36	7.33	2.24	2.49	4.85	0.25	0.75	1.12	0.75
choriocarcinoma cell line:SCH	10785-110H2	43.49	4.44	6.28	2.96	2.46	1.85	1.11	0.86	1.36	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	36.29	2.61	12.10	1.42	5.93	2.61	0.47	0.00	2.37	0.24
chorionic membrane cells, donor1	12238-129G6	23.65	1.99	2.85	1.14	0.85	1.14	0.28	0.00	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	33.51	2.98	4.08	0.99	0.89	1.69	0.40	0.30	0.60	0.40
chorionic membrane cells, donor3	12240-129G8	25.83	0.55	7.14	0.55	1.65	1.65	0.00	0.55	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	32.31	2.02	5.05	0.00	0.00	0.00	0.00	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	27.09	2.31	8.64	0.38	1.73	1.92	0.00	0.58	1.92	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	31.04	4.43	5.91	2.11	2.11	1.06	1.06	0.00	0.63	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	40.83	2.57	1.80	0.77	3.85	0.77	1.28	0.77	1.03	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	54.42	2.42	6.53	0.73	4.84	0.73	0.73	1.69	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	50.90	4.07	6.52	0.20	4.48	1.02	1.63	1.63	1.22	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	68.61	6.18	9.42	2.94	4.71	0.29	0.59	0.29	1.77	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	55.51	5.99	9.38	2.35	1.56	2.09	1.56	0.26	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	27.43	2.29	0.00	2.29	0.46	0.69	0.69	0.69	0.00	0.46
clear cell carcinoma cell line:TEN	10636-108I6	53.27	4.34	0.35	1.04	1.56	0.35	0.17	0.87	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	55.46	4.39	9.70	2.75	5.49	2.20	2.01	0.92	0.92	0.00
colon carcinoma cell line:COLO-320	10420-106C6	121.63	9.12	5.70	3.04	1.52	1.14	1.90	0.38	0.76	0.00
colon, adult, donor1	10082-102B1	49.98	4.76	2.38	1.19	0.00	0.00	1.19	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	42.07	3.53	3.64	0.82	0.47	1.18	0.35	0.12	0.24	0.82
colon, fetal, donor1	10070-101I7	25.34	1.85	0.62	0.62	0.00	1.24	1.24	1.24	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	146.67	27.50	4.58	4.58	4.58	0.00	9.17	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	101.56	14.02	15.30	5.10	5.95	8.92	1.70	0.00	0.85	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	49.35	6.49	12.98	2.57	1.36	4.68	0.91	0.75	1.81	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	44.00	5.92	15.79	2.26	1.83	5.50	1.41	0.28	1.55	0.28
corpus callosum, adult, pool1	10042-101F6	93.31	9.29	5.97	3.98	1.33	1.11	1.22	0.55	1.44	0.22
cruciate ligament, donor2	10295-104G7	30.80	4.05	0.81	1.62	0.00	1.62	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	44.94	4.01	0.80	3.21	0.80	1.61	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	43.44	4.32	6.00	2.16	0.24	1.44	0.48	0.72	2.16	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	27.78	5.05	0.23	3.21	0.23	0.23	0.46	0.00	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	39.49	4.10	4.10	0.77	1.80	2.05	0.26	0.77	0.77	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	28.89	5.30	2.65	6.26	0.48	1.44	0.24	0.72	0.96	0.48
ductus deferens, adult	10196-103E7	43.85	3.99	1.99	1.50	0.50	0.50	1.00	1.00	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	2.88	4.32	4.32	0.00	0.00	2.88	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	58.12	6.62	0.74	2.94	1.47	0.74	1.47	1.47	0.74	0.00
dura mater, adult, donor1	10041-101F5	44.35	5.29	2.89	1.57	0.74	0.83	0.83	0.17	0.66	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	92.83	15.55	7.33	7.77	5.33	4.66	2.00	1.55	1.11	3.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	50.15	5.73	2.01	2.29	3.73	1.29	0.43	2.01	0.57	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	40.08	3.08	6.78	4.32	0.00	1.85	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	47.53	3.63	4.24	1.21	1.51	0.91	1.51	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	56.81	4.01	6.17	1.85	0.62	0.93	0.62	0.31	1.85	0.00
embryonic pancreas cell line:2C6	10603-108E9	40.72	3.94	5.25	3.94	0.00	1.31	0.00	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	63.35	12.74	1.34	4.69	0.67	2.68	3.69	1.34	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	64.52	9.42	4.35	3.81	1.81	0.54	1.27	0.72	0.91	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	23.00	1.93	0.64	1.61	0.48	0.32	0.16	0.32	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	40.80	3.22	2.67	1.22	0.33	1.22	0.67	0.22	0.22	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	38.49	4.07	2.86	3.85	1.32	1.10	0.88	1.21	0.22	0.22
epididymis, adult	10197-103E8	43.54	5.23	2.51	1.05	0.21	0.63	0.63	0.00	0.21	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	49.14	5.32	1.77	1.24	0.89	0.35	0.35	0.00	0.89	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	22.81	3.54	3.15	0.79	0.39	1.18	1.18	0.00	0.39	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	37.22	1.97	13.76	1.05	4.32	2.10	0.39	0.52	1.97	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	46.75	4.04	17.13	2.36	4.92	2.66	1.08	0.10	2.36	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	34.95	2.80	15.01	1.90	3.70	1.46	0.34	0.56	1.34	0.00
esophagus, adult, pool1	10015-101C6	29.31	1.70	0.85	0.64	0.64	0.32	0.53	0.00	0.42	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	96.68	27.43	3.38	13.90	1.63	0.25	5.89	0.25	1.38	0.75
eye - muscle inferior rectus, donor1	10272-104E2	12.07	0.00	0.00	2.41	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	2.10	2.10	2.10	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	10.42	1.49	0.00	1.49	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	16.05	1.15	1.15	0.00	0.00	1.15	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	13.12	1.46	0.00	5.83	0.00	0.00	0.00	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	39.91	4.83	2.54	2.03	0.25	1.02	0.76	0.00	0.51	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	21.29	3.46	2.56	1.03	1.28	0.38	0.51	0.51	0.38	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	33.24	3.56	4.04	0.47	0.00	0.95	0.71	0.24	0.95	0.24
frontal lobe, adult, pool1	10040-101F4	70.93	13.70	10.51	9.19	1.13	1.88	2.63	0.84	1.97	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	129.11	11.71	22.82	6.61	2.70	6.00	2.10	0.90	2.70	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	125.09	5.03	4.75	1.83	6.86	1.37	0.91	2.19	1.19	0.46
gall bladder, adult	10198-103E9	35.25	5.55	0.97	1.21	0.97	0.72	0.48	0.00	1.21	1.21
gamma delta positive T cells, donor1	11937-126A2	136.90	4.83	3.76	0.00	5.37	0.54	0.00	1.61	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	114.29	7.84	5.23	2.24	2.61	0.37	2.24	0.37	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	24.08	1.90	3.59	1.27	0.42	1.69	0.42	0.00	0.63	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	29.98	1.16	5.22	0.58	0.77	0.97	0.00	0.39	0.58	0.00
gastric cancer cell line:AZ521	10549-107H9	57.06	6.89	7.05	0.82	2.62	0.66	1.15	0.49	0.66	0.16
gastric cancer cell line:GSS	10560-108A2	31.12	3.66	1.83	0.92	0.00	0.00	0.92	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	62.83	7.54	2.28	4.34	1.83	0.46	3.20	0.91	0.69	0.91
giant cell carcinoma cell line:LU65	10487-107B1	35.23	5.16	2.07	1.15	1.26	0.46	0.57	0.23	0.80	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	75.02	2.80	4.62	0.98	2.80	1.40	0.42	0.70	0.56	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	38.66	3.24	8.48	2.24	2.00	2.49	1.00	0.25	1.00	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	39.58	4.64	4.64	2.32	1.27	1.27	0.84	0.53	1.48	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	37.78	5.62	6.04	2.11	0.84	1.40	0.28	0.42	0.56	0.28
glioblastoma cell line:T98G	10485-107A8	25.28	2.43	1.66	0.88	1.21	0.77	1.10	0.11	0.77	0.00
glioma cell line:GI-1	10413-106B8	48.03	6.44	5.56	2.93	1.17	1.76	0.59	0.29	0.29	0.59
globus pallidus - adult, donor10196	10175-103C4	71.43	11.66	8.75	1.46	1.46	0.00	2.92	0.00	5.83	0.00
globus pallidus, adult, donor10252	10161-103A8	63.95	5.13	6.59	1.71	0.98	2.20	0.73	0.49	0.98	0.73
globus pallidus, adult, donor10258	10367-105F7	31.49	1.37	6.85	2.74	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	39.97	6.40	3.20	3.20	1.07	0.53	0.53	0.53	0.53	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	161.51	22.02	7.34	2.45	7.34	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	10.93	0.00	0.00	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	120.21	10.45	5.23	0.00	15.68	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	24.64	4.16	1.92	1.60	1.28	1.60	1.60	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	45.45	4.13	1.84	1.84	0.46	0.92	0.92	0.00	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	38.41	2.29	3.20	2.29	2.29	0.00	1.37	0.46	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	41.87	0.64	2.58	3.22	0.00	0.64	3.22	0.64	1.29	0.00
hIPS, biol_rep1	14380-156B6	37.37	1.44	0.00	4.31	2.87	0.00	5.75	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	46.64	3.43	0.69	0.69	0.69	0.00	0.69	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	58.48	5.52	3.31	3.31	0.00	2.21	2.21	1.10	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	28.73	8.05	3.74	2.87	0.57	1.72	2.30	0.00	1.44	0.00
heart - mitral valve, adult	10205-103F7	39.16	2.69	2.69	2.39	0.00	1.20	2.09	0.30	1.20	0.30
heart - pulmonic valve, adult	10206-103F8	39.74	5.23	2.88	1.57	0.52	1.31	1.31	0.00	1.57	0.26
heart - tricuspid valve, adult	10207-103F9	33.31	5.83	1.67	0.83	0.00	0.83	4.16	0.00	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	35.51	3.26	2.65	2.65	0.61	1.22	1.02	0.61	0.61	0.20
heart, adult, diseased, donor1	10051-101G6	43.86	2.98	5.96	0.43	0.85	2.13	1.70	0.85	0.43	0.00
heart, adult, pool1	10016-101C7	29.67	0.69	3.22	0.00	0.46	1.84	0.46	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	73.31	7.91	7.50	3.39	0.92	1.44	1.44	0.51	0.92	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	25.92	3.39	3.09	2.16	0.00	0.00	0.00	0.00	0.93	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	14.27	2.38	5.95	3.57	0.00	0.00	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	64.09	7.96	12.04	3.98	1.88	3.31	2.10	1.10	0.99	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	60.69	8.37	9.71	2.79	1.94	2.55	1.70	1.21	0.73	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	68.01	8.99	13.64	4.14	2.02	3.44	2.63	0.91	1.11	0.00
hepatoma cell line:Li-7	10484-107A7	45.93	4.78	6.56	2.56	1.56	2.00	2.11	0.78	0.44	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	27.54	4.22	0.80	0.90	0.70	0.30	1.01	0.20	0.40	0.20
hippocampus - adult, donor10196	10169-103B7	53.94	9.46	12.30	5.68	1.89	3.79	0.95	0.95	2.84	2.84
hippocampus, adult, donor10252	10153-102I9	59.80	5.92	5.51	4.08	1.02	1.02	1.43	1.02	0.61	0.00
hippocampus, adult, donor10258	10374-105G5	58.76	3.98	4.48	7.47	0.50	1.00	1.99	1.00	1.99	0.00
hippocampus, newborn, donor10223	10363-105F3	29.26	6.34	2.47	9.16	0.35	0.35	2.47	0.00	0.70	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	45.78	4.27	4.27	1.83	1.83	1.83	0.61	0.61	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	34.36	3.53	1.37	0.98	0.98	0.98	0.79	0.59	0.00	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	40.62	4.57	1.78	2.03	2.03	0.25	0.51	0.25	0.00	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	63.72	8.46	1.13	5.07	2.26	2.26	2.82	0.56	0.56	11.28
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	82.63	7.75	1.03	1.55	1.55	0.52	1.55	0.00	0.52	14.98
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	72.51	7.59	3.42	3.42	2.28	0.76	0.76	0.00	0.38	11.01
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	67.15	7.88	3.21	3.50	1.46	0.88	1.46	0.88	1.17	9.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	52.13	8.19	2.80	4.31	1.29	1.72	1.51	0.22	0.22	9.91
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	50.88	6.26	4.17	5.00	1.67	2.09	1.25	0.42	0.83	4.59
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	60.86	7.58	5.92	4.50	2.13	1.42	1.89	0.71	0.71	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	52.07	7.88	4.98	4.98	1.77	1.61	1.61	0.80	0.48	5.14
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	72.72	14.14	1.35	6.06	3.37	1.35	0.67	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	31.30	3.44	1.10	0.47	1.41	0.47	1.25	0.31	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	32.43	2.95	3.44	1.97	0.49	1.47	0.49	0.00	0.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	48.00	0.87	0.87	0.87	2.62	0.87	0.87	0.87	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	61.09	8.40	0.95	3.05	0.57	0.76	1.91	0.38	0.00	12.22
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	58.43	6.98	2.18	3.92	0.87	0.00	1.31	0.87	1.31	6.98
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	113.45	8.50	5.00	6.50	2.00	0.00	1.00	1.50	0.50	12.49
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	50.11	4.71	3.39	3.20	0.75	0.94	1.13	0.38	0.19	6.22
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	65.02	10.46	2.73	5.00	0.45	0.45	1.82	0.00	0.00	7.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	68.29	8.77	3.13	5.64	0.63	0.63	1.88	0.94	1.25	9.08
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	53.89	11.76	3.92	3.92	1.63	2.12	0.82	0.33	0.16	6.86
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	44.13	6.97	2.90	4.06	1.74	2.61	0.58	0.00	0.87	2.61
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	57.39	10.16	2.69	8.07	0.90	2.69	2.39	0.60	0.00	8.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	37.69	5.54	2.59	0.37	1.85	0.92	0.55	0.00	0.92	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	34.80	4.28	1.71	0.57	1.43	1.14	0.29	0.29	0.86	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	51.45	3.27	2.04	1.22	1.63	1.22	2.86	0.00	0.82	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	62.67	5.63	3.87	3.52	0.00	1.41	1.76	1.06	0.70	8.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	44.03	4.12	4.12	2.22	0.63	1.27	1.90	0.32	0.63	5.38
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	56.29	7.26	3.93	3.33	1.82	0.91	3.03	0.00	0.00	5.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	41.37	5.69	1.55	6.21	0.52	2.59	1.03	0.52	1.03	8.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	48.48	9.30	0.66	1.33	2.66	0.66	1.33	0.00	0.00	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	59.26	6.93	0.77	3.85	1.03	1.28	2.31	1.28	0.51	5.13
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	46.27	6.14	2.30	4.35	2.05	2.05	1.53	0.26	0.26	4.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	47.71	6.06	4.54	1.51	0.76	2.27	4.54	0.76	0.00	5.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	50.41	6.39	1.68	4.37	2.02	1.68	2.69	0.00	0.67	4.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	36.71	3.86	1.93	0.97	0.72	0.48	2.17	0.00	0.00	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	53.92	5.35	2.23	1.78	3.12	0.45	3.12	0.45	0.45	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	36.10	3.90	1.46	1.95	1.95	0.49	1.95	0.00	0.49	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	46.76	6.42	2.75	3.06	2.75	1.22	1.83	0.31	0.00	5.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	91.09	6.51	42.29	3.25	0.00	3.25	0.00	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	78.10	4.63	3.31	2.98	3.31	0.66	0.66	0.33	0.66	8.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	63.49	5.47	1.64	1.64	1.09	0.55	1.09	1.09	0.00	9.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	65.86	10.49	1.81	5.79	0.72	0.36	2.53	1.45	0.36	9.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	55.16	6.76	3.56	2.85	1.07	1.07	1.07	1.07	0.36	7.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	53.70	9.55	0.00	5.97	1.19	1.19	1.19	1.19	1.19	4.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	65.82	8.13	4.33	4.74	1.08	1.76	2.17	0.41	0.41	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	62.77	11.58	1.35	5.93	2.16	1.62	1.08	0.54	0.81	4.58
immature langerhans cells, donor1	11904-125F5	45.28	4.12	5.57	2.18	2.66	1.70	0.97	0.00	0.48	0.48
immature langerhans cells, donor2	11905-125F6	54.66	5.54	3.96	3.17	4.75	1.58	0.79	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	74.38	17.79	10.69	9.94	1.04	2.37	4.07	0.09	2.65	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	45.52	4.55	5.53	3.25	2.28	0.33	0.33	0.33	0.65	2.28
kidney, adult, pool1	10017-101C8	48.66	4.61	2.60	2.00	0.90	0.90	0.90	0.20	0.10	0.20
kidney, fetal, pool1	10045-101F9	72.22	7.92	1.63	2.76	0.64	0.71	2.05	0.21	0.21	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	64.05	9.23	3.98	5.11	1.56	1.42	1.42	0.85	0.71	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	35.67	2.90	2.35	0.69	0.41	0.97	0.97	0.14	0.69	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	50.65	6.06	3.12	3.49	0.73	0.55	1.10	0.00	0.37	0.37
left atrium, adult, donor1	10079-102A7	18.52	1.09	3.27	0.54	0.00	0.54	0.54	0.00	0.54	1.63
left ventricle, adult, donor1	10078-102A6	13.15	1.01	1.52	0.51	1.01	0.00	1.01	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	27.09	3.01	9.03	1.09	0.82	0.27	1.09	0.00	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	22.99	2.16	0.72	1.08	0.36	0.72	1.08	0.00	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	16.30	3.26	1.09	0.00	0.54	0.54	0.54	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	21.12	2.67	2.19	0.73	0.00	0.97	0.73	0.73	1.21	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	12.70	6.35	12.70	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	25.09	4.18	2.09	1.05	0.00	1.05	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	46.75	10.15	5.31	4.60	0.35	1.53	1.65	0.24	0.24	0.24
liposarcoma cell line:KMLS-1	10782-110G8	48.58	6.87	7.65	2.50	0.47	0.94	1.09	0.31	2.97	0.16
liposarcoma cell line:SW 872	10726-110A6	27.90	2.92	2.56	1.95	1.46	0.49	0.37	0.97	0.61	0.00
liver, adult, pool1	10018-101C9	29.66	2.59	3.40	1.30	0.00	0.00	0.32	0.16	0.65	0.49
liver, fetal, pool1	10086-102B5	27.28	0.94	1.88	0.00	0.00	0.00	0.00	0.00	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	44.04	8.46	3.06	3.94	0.44	1.31	1.60	0.73	1.90	0.15
locus coeruleus, adult, donor10252	10165-103B3	53.52	7.20	7.38	2.77	1.29	1.48	1.29	0.37	0.92	0.00
locus coeruleus, adult, donor10258	10375-105G6	37.24	7.90	3.95	7.05	0.00	1.13	0.56	0.28	1.69	0.85
locus coeruleus, newborn, donor10223	10362-105F2	61.41	5.05	10.52	2.52	1.68	2.10	0.00	0.00	0.42	0.84
lung adenocarcinoma cell line:A549	10499-107C4	49.82	4.01	8.58	0.55	1.52	0.69	0.69	0.55	1.38	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	46.19	2.76	5.52	0.00	0.00	2.07	0.00	0.00	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	44.82	2.37	1.05	0.66	0.53	0.53	0.40	0.66	0.13	0.26
lung, adult, pool1	10019-101D1	30.71	2.60	2.48	0.71	0.35	0.71	0.24	0.24	0.24	0.59
lung, fetal, donor1	10068-101I5	87.62	5.14	5.71	4.28	2.00	3.42	2.85	0.86	0.57	0.29
lung, right lower lobe, adult, donor1	10075-102A3	39.86	1.83	1.83	1.83	1.37	0.92	0.46	0.00	1.83	1.37
lymph node, adult, donor1	10077-102A5	29.35	3.31	0.95	0.47	0.95	0.95	0.95	0.00	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	32.88	1.10	8.11	0.44	1.10	0.66	0.00	0.00	1.10	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	46.79	7.85	0.00	1.66	3.17	0.15	0.45	0.30	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	177.54	6.80	5.95	5.10	12.74	5.10	0.00	1.70	0.85	0.00
mature adipocyte, donor1	12231-129F8	38.63	2.66	0.89	1.78	0.89	0.89	1.78	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	46.49	3.94	1.66	2.49	0.21	2.49	0.83	0.42	0.62	0.00
mature adipocyte, donor3	12233-129G1	39.83	3.56	0.47	1.66	0.24	2.61	1.42	0.00	0.47	0.24
mature adipocyte, donor4	12234-129G2	38.43	2.90	2.63	1.84	1.05	1.84	0.79	0.79	0.53	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	78.39	8.34	7.86	2.38	4.77	0.24	1.43	0.71	2.14	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	68.81	10.15	10.15	10.15	0.00	4.51	3.38	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	68.78	6.80	9.20	3.49	1.10	2.21	2.57	0.18	1.84	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	60.04	6.99	7.62	6.04	0.00	0.64	2.86	0.32	1.91	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	44.35	9.38	6.82	4.26	0.43	0.85	2.13	0.85	2.99	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	66.83	15.53	8.78	10.63	0.51	2.19	2.36	0.17	2.87	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	62.39	11.46	5.52	4.03	0.64	1.06	2.55	0.64	0.64	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	3.85	5.78	13.48	0.00	0.00	7.71	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	0.00	0.00	14.35	0.00	0.00	0.00	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	36.25	4.67	3.59	7.18	0.72	1.44	2.51	0.36	2.15	1.08
medulla oblongata - adult, donor10196	10174-103C3	61.65	12.98	4.54	1.95	0.65	1.95	1.30	0.00	2.60	0.00
medulla oblongata, adult, donor10252	10155-103A2	57.90	4.02	4.33	1.86	0.93	1.70	0.46	0.31	1.86	0.15
medulla oblongata, adult, pool1	10038-101F2	56.32	9.39	8.08	4.65	0.73	2.61	1.63	0.57	2.69	0.41
medulla oblongata, newborn, donor10223	10361-105F1	57.98	4.17	2.08	2.78	1.74	0.00	0.69	0.69	0.69	1.04
medulloblastoma cell line:D283 Med	10838-111E1	96.98	13.06	1.55	7.09	1.33	1.55	4.87	0.89	0.89	0.22
medulloblastoma cell line:ONS-76	10759-110E3	15.28	0.73	2.93	0.12	0.86	0.73	0.24	0.24	0.49	0.00
melanoma cell line:COLO 679	10514-107E1	43.84	4.02	6.47	1.29	1.01	1.44	0.57	0.57	0.72	0.43
melanoma cell line:G-361	10465-106H6	42.89	5.70	7.33	4.89	1.36	3.53	2.17	0.27	1.63	0.27
meningioma cell line:HKBMM	10691-109F7	26.23	1.09	1.09	0.18	1.27	0.36	0.90	0.00	0.54	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	78.42	12.34	8.81	7.93	0.88	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	78.80	8.81	1.81	8.55	0.78	0.52	2.07	0.00	0.52	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	20.56	2.30	1.99	1.23	0.31	0.61	0.77	0.15	0.15	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	24.36	6.00	1.82	1.64	0.73	0.73	1.45	0.36	0.73	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	20.29	1.66	0.83	2.07	0.83	0.00	0.41	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.84	2.67	2.39	1.55	0.42	0.56	0.98	0.00	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.60	3.47	1.93	1.93	0.19	1.54	0.96	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	18.05	6.25	1.39	0.69	0.00	2.78	0.69	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	29.01	2.06	2.23	1.89	0.86	0.69	0.51	0.00	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	25.53	2.88	1.38	1.96	0.35	0.69	0.92	0.12	0.58	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.15	2.92	2.25	1.33	0.40	0.80	0.66	0.27	0.27	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	22.55	2.84	3.78	1.49	0.95	1.22	0.68	0.14	0.27	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	21.48	2.13	3.13	1.42	0.28	0.85	0.57	0.00	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	33.59	4.28	1.65	2.63	0.99	0.99	0.99	0.33	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	24.63	4.57	1.52	1.25	0.28	0.69	0.83	0.14	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	24.09	4.19	0.70	1.05	0.00	0.00	0.70	0.70	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	15.72	1.63	1.22	1.84	0.41	0.00	0.61	0.41	0.20	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	25.52	3.95	2.88	1.80	0.72	0.72	0.00	1.08	0.00	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.66	1.45	2.48	1.45	0.21	0.10	1.03	0.10	0.21	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	18.47	2.96	0.46	0.91	0.23	0.68	0.23	0.00	0.68	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	24.75	2.52	1.68	1.68	1.26	1.26	1.68	0.00	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	22.86	2.69	1.94	0.75	0.15	0.30	0.15	0.75	0.45	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	25.30	2.45	0.96	1.84	0.26	0.61	0.79	0.09	0.26	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	32.40	4.79	0.74	5.15	0.00	0.37	1.10	0.37	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	29.47	3.72	0.86	1.43	0.57	0.86	0.57	0.29	0.57	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	32.42	2.95	8.42	2.11	0.84	0.84	1.26	0.00	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	35.16	2.74	1.37	3.20	0.46	0.00	1.37	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	36.32	2.81	1.28	1.53	0.77	0.77	0.26	0.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	32.98	4.19	0.52	2.36	1.05	0.52	1.05	0.00	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	37.59	2.46	1.23	0.92	0.31	0.00	0.62	0.00	0.92	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	32.01	5.18	1.65	0.47	0.94	1.41	0.71	0.00	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	37.23	2.71	1.35	3.38	0.34	0.68	1.35	0.00	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	34.58	4.32	0.39	0.79	1.18	0.39	0.00	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	26.41	4.63	1.39	1.39	1.39	0.00	0.46	0.00	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	38.65	4.61	0.58	1.44	1.73	0.29	1.73	0.58	0.29	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	31.01	4.02	1.12	1.56	0.89	0.45	0.22	0.00	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	33.65	3.61	0.96	1.20	0.48	0.24	1.44	0.00	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	42.53	5.13	2.20	2.20	0.73	1.47	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	33.23	5.71	1.01	0.67	0.67	0.34	0.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	37.66	3.68	0.41	2.05	0.41	0.82	0.82	0.41	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	38.23	3.01	0.43	3.44	0.00	0.86	0.43	1.29	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	8.20	0.00	2.73	0.00	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00	5.16	0.00	0.00	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	26.63	2.92	0.32	3.57	0.97	0.00	1.30	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	23.28	4.36	2.91	1.45	2.91	1.45	2.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	25.05	1.60	2.13	3.73	1.07	0.00	1.07	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	31.08	7.36	1.64	3.27	0.00	0.00	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	27.60	4.28	0.39	2.33	0.39	0.39	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	31.48	0.00	0.00	2.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	26.82	1.99	0.99	0.99	0.00	0.99	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	4.77	0.00	4.77	0.00	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	29.65	4.74	1.19	1.78	0.59	0.59	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	20.71	2.44	1.22	1.22	1.22	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	24.70	3.17	1.27	2.53	0.63	0.00	0.63	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	24.14	4.14	0.00	3.45	0.34	1.38	1.03	0.00	0.00	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	32.24	6.45	0.00	2.15	0.00	2.15	4.30	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	65.43	6.89	0.00	6.89	0.00	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	35.86	4.48	1.63	5.30	1.22	0.41	0.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	32.57	8.74	0.79	1.59	0.00	1.59	2.38	0.79	0.00	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	45.39	5.31	0.00	5.90	0.00	2.36	0.59	0.00	0.00	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	41.14	8.10	0.94	3.74	0.94	0.31	0.94	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	42.77	1.34	1.34	5.35	0.00	1.34	4.01	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	35.48	2.37	0.00	3.55	1.18	0.00	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	51.36	2.57	2.57	2.57	0.00	0.00	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	39.24	7.57	0.00	2.07	0.00	0.69	0.69	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	45.52	3.96	4.45	1.48	0.49	2.47	0.49	0.49	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	50.47	4.49	1.12	3.36	0.00	1.12	0.00	0.00	2.24	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	50.89	3.82	1.27	3.82	0.64	4.45	1.91	0.00	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	48.76	4.84	5.64	4.43	1.21	1.61	0.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	39.25	4.36	10.90	2.18	0.00	0.00	0.00	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	45.61	2.53	3.80	1.27	1.27	2.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	43.09	2.43	3.03	4.25	0.00	0.00	0.61	0.00	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	67.78	0.00	0.00	4.52	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	46.95	7.41	4.12	1.65	0.82	0.82	0.00	0.00	0.82	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	51.99	4.96	1.79	4.56	1.39	0.79	1.59	0.20	1.19	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	31.15	3.57	0.97	4.22	0.32	2.27	0.32	0.65	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	29.54	3.06	1.02	6.11	0.00	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	31.72	7.74	2.32	4.64	0.00	0.00	1.55	0.77	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	37.80	5.67	6.38	1.42	0.71	0.71	1.18	0.24	1.42	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	38.23	6.49	8.11	3.71	0.93	4.87	1.39	0.46	0.93	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	12.82	0.00	0.00	0.00	0.00	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	41.00	4.93	2.26	2.77	1.34	1.13	0.92	0.41	0.41	0.51
mesothelioma cell line:Mero-25	10850-111F4	23.38	7.49	1.13	5.22	0.68	1.82	1.13	1.13	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	27.38	3.67	3.18	0.98	1.47	1.96	0.24	0.73	0.73	0.49
mesothelioma cell line:Mero-48a	10852-111F6	20.15	1.99	1.99	1.99	0.66	0.89	0.89	0.44	0.66	0.00
mesothelioma cell line:Mero-82	10853-111F7	38.37	11.04	3.15	5.52	0.26	1.05	1.58	0.53	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	24.34	5.11	3.06	3.92	0.85	1.53	1.02	0.68	0.34	0.68
mesothelioma cell line:Mero-84	10855-111F9	30.33	3.29	5.06	2.78	1.52	0.51	0.76	0.25	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	21.53	2.69	2.48	1.45	0.21	0.62	0.83	0.00	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	47.87	8.78	3.31	3.98	1.66	0.99	1.16	0.50	1.16	0.00
mesothelioma cell line:NCI-H226	10846-111E9	21.72	4.34	1.45	1.63	1.27	1.45	0.36	0.18	0.36	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	26.82	4.78	2.22	1.02	0.68	1.20	0.51	0.51	1.20	0.34
mesothelioma cell line:NCI-H28	10845-111E8	36.13	4.58	3.31	2.54	1.02	1.27	1.02	1.02	0.51	0.25
mesothelioma cell line:No36	10857-111G2	36.53	2.28	3.59	1.96	0.65	1.30	0.98	1.30	1.96	0.33
mesothelioma cell line:ONE58	10858-111G3	20.32	3.52	1.08	0.81	1.63	1.63	0.54	0.54	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	38.96	3.45	5.18	1.54	1.73	0.00	0.38	0.00	0.58	0.19
migratory langerhans cells, donor2	11902-125F3	41.64	2.69	2.32	1.34	1.22	0.49	0.37	0.24	0.12	0.24
migratory langerhans cells, donor3	11903-125F4	37.87	3.59	3.05	0.54	0.18	0.36	0.90	0.36	0.54	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	35.91	3.92	4.57	1.96	0.33	1.63	0.65	0.33	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	24.58	5.72	0.00	2.54	0.21	0.42	0.85	0.00	0.00	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	28.79	2.30	2.53	0.46	0.23	0.00	0.46	0.00	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	30.83	4.00	6.66	1.90	1.33	0.38	1.14	0.19	0.57	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	57.66	2.96	6.10	0.37	2.40	0.55	0.37	0.37	0.18	0.18
myeloma cell line:PCM6	10474-106I6	63.65	3.36	4.15	0.59	1.58	0.79	0.00	0.20	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	20.80	5.58	6.09	3.55	0.51	0.51	1.01	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	30.01	4.32	3.14	1.18	0.59	0.39	0.39	0.59	0.20	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	40.45	2.45	1.00	0.89	1.67	0.56	0.45	1.23	0.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	53.46	1.62	1.47	1.76	2.79	0.66	0.51	0.66	0.22	0.00
nasal epithelial cells, donor2	12227-129F4	34.78	4.42	0.00	0.00	0.55	0.00	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	105.14	35.20	7.13	13.57	2.30	2.30	8.05	1.61	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	1486.21	275.39	242.84	105.52	23.39	52.57	67.72	5.24	30.12	3.93
neuroblastoma cell line:NBsusSR	10607-108F4	56.10	9.70	5.69	5.27	1.48	1.05	1.69	0.63	0.63	0.00
neuroblastoma cell line:NH-12	10555-107I6	101.37	16.40	3.54	10.25	1.12	0.75	7.45	0.19	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	47.68	12.34	1.19	3.80	0.47	0.24	4.51	0.00	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	53.37	7.29	1.58	3.17	0.63	0.79	1.27	0.00	0.00	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	28.58	4.63	1.81	1.61	0.40	1.61	1.81	0.20	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	20.98	3.18	1.27	1.27	0.64	0.00	0.64	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	19.96	2.93	1.60	0.80	0.00	0.00	1.33	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	104.12	0.00	0.00	29.75	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	119.53	26.56	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	123.12	9.47	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	81.85	8.96	0.51	1.35	2.20	0.17	1.18	0.51	0.17	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	124.08	8.81	11.21	5.60	2.40	5.60	4.80	0.00	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	31.74	4.17	0.32	1.60	0.96	0.00	0.00	0.64	1.60	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	26.54	2.89	2.89	1.84	1.05	1.31	0.79	0.00	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	76.40	11.44	12.28	7.69	1.03	2.44	2.72	1.03	2.16	0.19
occipital cortex - adult, donor10196	10172-103C1	70.05	6.18	8.24	4.12	2.06	2.06	4.12	2.06	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	66.29	6.98	7.25	3.22	0.54	1.88	1.88	0.81	1.34	0.54
occipital cortex, newborn, donor10223	10355-105E4	45.86	8.37	3.64	8.73	0.36	0.73	1.09	0.36	1.46	1.09
occipital lobe, adult, donor1	10076-102A4	56.15	10.23	4.99	7.35	0.52	0.79	3.15	0.52	1.84	0.79
occipital lobe, fetal, donor1	10073-102A1	75.95	20.17	3.86	8.58	0.43	0.43	3.43	0.86	0.43	0.86
occipital pole, adult, pool1	10036-101E9	70.17	12.69	6.94	5.36	0.39	1.50	3.07	0.39	2.44	0.24
olfactory region, adult	10195-103E6	42.03	7.83	6.11	5.54	0.76	0.76	1.72	0.76	1.15	0.00
optic nerve, donor1	10277-104E7	38.02	2.00	2.00	0.00	0.00	0.00	2.00	0.00	0.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	67.89	6.38	10.25	2.73	2.73	3.87	0.68	2.05	0.57	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	45.61	1.79	3.57	0.41	1.10	0.69	0.82	0.14	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	32.51	1.35	2.20	1.69	1.02	0.85	0.68	0.51	0.34	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	34.08	3.70	1.96	0.69	1.04	0.58	0.58	0.12	0.23	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	27.93	4.70	2.06	1.76	1.76	1.18	0.88	0.29	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	42.98	9.34	2.80	0.93	0.93	0.93	1.87	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	46.65	4.03	7.42	1.27	1.48	1.91	0.85	0.85	0.21	0.00
ovary, adult, pool1	10020-101D2	44.29	4.54	1.14	1.05	0.52	0.09	1.31	0.17	0.17	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	44.55	7.33	2.57	5.13	1.47	0.18	2.38	0.73	0.55	0.00
pancreas, adult, donor1	10049-101G4	31.04	6.58	2.82	0.00	0.00	0.00	0.94	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	22.64	3.35	5.31	1.96	1.40	1.68	1.12	0.28	0.84	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	28.28	3.07	1.36	1.36	0.34	0.68	1.19	0.17	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	68.88	4.97	5.80	1.49	2.48	1.82	0.99	0.17	0.99	0.33
paracentral gyrus, adult, pool1	10035-101E8	64.43	12.54	11.44	7.60	0.92	1.65	3.29	0.55	2.47	0.37
parietal cortex, adult, donor10258	10373-105G4	52.11	5.14	4.40	2.20	0.73	0.00	2.20	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	67.71	7.52	6.58	8.46	2.82	1.88	2.82	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	54.44	6.27	6.56	5.42	0.29	0.86	0.86	0.86	2.00	0.00
parietal lobe, adult, pool1	10034-101E7	65.74	12.34	11.81	7.05	0.53	1.85	3.08	0.26	1.94	0.00
parietal lobe, fetal, donor1	10072-101I9	69.83	20.37	0.97	3.88	0.00	0.00	7.76	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	42.25	8.97	4.11	10.09	0.75	1.87	2.24	0.37	0.37	0.75
parotid gland, adult	10199-103F1	25.28	1.85	0.62	1.23	0.00	0.62	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	39.75	4.30	1.07	1.07	0.54	1.61	1.61	1.61	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	28.82	3.72	0.74	0.19	1.49	0.00	0.37	0.19	0.37	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	29.58	1.89	1.31	1.46	0.87	0.58	0.15	0.29	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	59.34	11.61	8.39	10.97	1.29	1.29	1.94	1.29	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	127.33	12.44	23.69	5.33	1.18	3.55	1.78	1.18	2.96	0.00
pineal gland, adult, donor10258	10377-105G8	66.47	11.29	8.15	5.64	0.00	1.25	1.25	0.63	2.51	0.00
pituitary gland - adult, donor10196	10180-103C9	120.40	11.13	10.12	6.07	1.01	2.02	3.04	0.00	3.04	0.00
pituitary gland, adult, donor10252	10162-103A9	151.66	11.99	13.03	3.65	2.08	0.52	1.56	1.04	1.04	0.52
pituitary gland, adult, donor10258	10378-105G9	84.27	11.07	5.11	0.85	0.00	1.70	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	40.21	1.94	3.87	1.51	1.51	2.37	1.18	0.22	0.75	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	53.63	3.44	0.26	0.66	0.79	0.53	1.32	0.53	0.40	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	33.46	3.58	1.09	0.47	0.93	1.56	0.47	0.31	0.16	0.00
pons, adult, pool1	10033-101E6	59.13	9.81	9.73	6.02	0.86	2.41	3.44	0.60	2.67	0.34
postcentral gyrus, adult, pool1	10032-101E5	76.80	12.81	9.85	7.41	0.26	1.31	2.18	0.52	2.62	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	64.83	4.18	2.09	4.18	4.18	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	82.62	5.51	5.51	0.00	5.51	0.00	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	82.15	11.74	0.00	0.00	0.00	0.00	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	41.80	2.91	6.41	1.02	2.62	0.87	0.44	0.73	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	45.19	3.99	5.81	1.45	1.45	0.91	0.54	0.36	0.36	0.18
prostate, adult, pool1	10022-101D4	35.64	2.90	1.81	1.09	0.18	0.18	0.82	0.27	0.27	0.36
putamen, adult, donor10196	10176-103C5	69.40	13.22	15.34	3.07	0.71	2.12	0.94	0.94	2.60	0.47
putamen, adult, donor10252	10152-102I8	68.63	11.76	3.92	0.00	1.96	3.92	1.96	0.00	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	48.08	4.37	4.37	3.28	2.19	0.00	0.00	1.09	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	52.67	6.52	8.46	3.87	0.72	2.17	1.21	0.24	1.69	0.24
putamen, newborn, donor10223	10365-105F5	77.96	6.75	9.00	1.50	3.00	1.50	1.50	3.00	3.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	35.49	3.78	9.60	1.45	0.87	1.16	0.58	0.58	0.58	0.00
rectum, fetal, donor1	10067-101I4	41.73	6.95	4.17	4.17	0.00	2.78	1.39	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	50.03	2.54	0.85	1.70	2.97	0.42	0.64	2.33	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	39.35	1.66	0.41	0.00	0.83	0.00	0.41	0.00	0.41	0.00
retina, adult, pool1	10030-101E3	67.89	7.75	5.17	2.48	0.89	1.09	0.89	0.80	0.70	0.00
retinoblastoma cell line:Y79	10475-106I7	117.95	22.34	5.20	6.75	2.86	0.52	5.72	1.30	0.78	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	33.69	3.20	2.46	0.74	0.74	0.25	0.98	0.37	0.61	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	57.08	7.59	2.25	1.69	1.97	0.56	0.84	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	29.56	0.76	0.76	0.00	0.00	0.76	0.00	0.00	0.76	0.76
salivary acinar cells, donor1	11771-123I7	30.43	3.08	2.10	0.49	0.65	0.32	0.81	0.49	0.32	0.16
salivary acinar cells, donor2	11772-123I8	40.48	2.34	1.51	1.38	0.96	0.41	0.96	0.41	0.14	0.41
salivary acinar cells, donor3	11773-123I9	24.50	3.97	1.32	0.00	0.00	0.00	0.00	0.00	0.66	0.66
salivary gland, adult, pool1	10093-102C3	33.17	0.57	0.00	1.14	1.72	1.14	1.14	1.14	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	54.30	7.42	4.30	2.78	2.28	1.94	1.18	0.25	1.10	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	47.61	7.17	5.88	2.94	1.88	0.47	1.18	0.47	1.06	0.24
seminal vesicle, adult	10201-103F3	39.15	6.35	3.70	2.12	1.06	0.00	0.53	0.00	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	34.98	6.07	0.73	3.89	0.73	1.21	0.73	0.49	0.00	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	28.94	3.02	0.25	3.27	0.50	0.00	0.50	0.75	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	28.10	3.01	1.00	5.02	2.01	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	48.76	8.06	0.54	5.24	0.67	0.67	2.15	0.67	0.13	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	72.95	5.42	4.09	1.88	3.21	0.44	0.66	0.77	0.55	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	38.32	3.48	7.74	1.29	0.90	2.06	0.65	0.26	0.77	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	25.54	2.13	0.71	2.13	0.00	0.71	0.71	0.00	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	33.70	3.24	1.68	0.84	0.24	0.72	0.36	0.24	0.24	1.08
skeletal muscle, fetal, donor1	10066-101I3	28.14	7.04	5.03	1.01	1.01	0.00	3.02	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	13.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	32.19	3.16	1.26	1.26	1.26	0.00	1.89	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	39.36	3.00	2.00	0.67	2.00	0.33	0.67	0.33	1.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	87.63	13.55	5.99	5.04	1.58	1.58	4.10	0.00	0.95	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	62.64	4.24	3.08	1.73	1.54	0.19	1.35	0.58	1.16	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	83.24	4.78	7.58	1.65	2.31	2.14	0.16	1.15	1.32	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	90.88	12.87	0.80	4.18	2.73	0.64	3.86	1.13	0.64	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	90.22	15.04	6.10	4.58	3.92	1.96	1.53	1.74	1.31	0.00
small intestine, adult, pool1	10024-101D6	48.25	3.46	7.05	1.19	1.55	1.07	0.84	0.00	0.60	0.00
small intestine, fetal, donor1	10064-101I1	37.35	4.42	5.90	0.98	0.74	0.74	0.49	0.00	1.23	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	74.88	5.64	3.59	2.56	2.05	2.05	0.51	1.03	1.03	0.00
smooth muscle, adult, pool1	10048-101G3	26.36	2.84	0.78	1.03	0.26	0.26	1.29	0.00	0.78	0.26
somatostatinoma cell line:QGP-1	10781-110G7	49.05	2.41	1.88	1.61	1.88	1.07	1.07	0.27	0.80	0.00
spinal cord - adult, donor10196	10181-103D1	44.50	7.57	5.05	4.13	1.15	1.61	0.46	0.00	1.84	0.00
spinal cord, adult, donor10252	10159-103A6	59.93	5.52	1.97	2.76	2.76	1.58	1.18	1.18	1.18	0.00
spinal cord, adult, donor10258	10369-105F9	63.65	3.46	4.84	2.08	1.38	1.38	1.38	0.69	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	48.18	7.93	4.88	6.10	1.22	1.83	0.61	0.61	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	73.93	4.59	5.05	3.21	2.30	0.92	0.92	1.38	1.38	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	25.99	3.44	1.49	1.05	0.90	0.30	0.45	0.75	0.60	0.00
spleen, adult, pool1	10025-101D7	43.61	3.41	4.30	1.32	0.88	0.99	0.44	0.44	0.22	0.66
spleen, fetal, pool1	10044-101F8	52.52	4.29	3.50	2.22	0.72	0.24	0.95	0.40	0.48	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	36.33	8.59	2.90	2.48	1.14	0.72	1.76	0.21	0.93	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	71.96	4.18	4.56	1.33	3.61	1.14	1.14	0.38	0.57	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	46.13	3.49	7.34	3.84	1.75	3.15	1.05	1.05	2.10	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	40.27	4.30	0.78	2.74	2.35	0.39	0.39	0.00	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	122.35	6.98	5.29	1.69	10.81	3.83	0.90	4.28	1.35	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	60.15	1.27	3.39	2.12	5.08	0.42	0.42	0.42	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	30.88	5.92	2.96	0.85	0.42	0.85	0.00	0.00	0.85	0.00
stomach, fetal, donor1	10062-101H8	30.97	6.41	1.07	3.20	0.00	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	48.42	1.14	1.14	0.57	0.57	0.00	0.57	0.00	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	60.23	3.74	5.61	1.04	1.25	1.66	1.66	1.04	0.83	0.00
substantia nigra, adult, donor10258	10371-105G2	49.14	6.21	6.72	10.35	0.00	1.03	1.55	0.52	2.59	0.00
substantia nigra, newborn, donor10223	10358-105E7	48.05	7.07	2.12	2.83	2.12	1.41	0.00	1.41	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	68.32	9.17	7.11	2.98	1.83	1.83	1.38	1.15	1.60	0.00
temporal lobe, adult, pool1	10031-101E4	67.82	15.26	7.21	6.78	0.93	1.70	2.71	0.17	1.78	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	69.09	21.37	1.42	12.11	0.00	1.42	2.85	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	60.66	11.43	2.20	14.50	0.44	1.76	1.76	0.00	0.44	0.00
tenocyte, donor1	11763-123H8	29.67	5.24	1.40	1.75	0.35	0.00	0.70	0.35	0.70	0.00
tenocyte, donor2	11765-123I1	41.58	5.34	0.76	4.20	0.00	1.14	1.14	0.00	0.76	0.38
tenocyte, donor3	11768-123I4	32.25	5.19	5.19	1.85	0.00	0.74	1.48	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	41.81	8.16	12.92	5.61	2.04	2.04	3.91	0.17	2.21	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	48.86	6.17	4.47	1.70	2.62	0.62	0.92	0.31	0.46	0.15
teratocarcinoma cell line:PA-1	10807-111A6	32.24	3.10	3.41	1.08	2.17	1.86	1.39	0.00	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	37.58	5.20	7.36	3.30	3.55	3.43	1.78	0.25	1.90	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	92.27	10.59	12.86	10.97	7.19	4.92	3.78	0.38	2.27	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	58.78	7.85	20.50	3.93	4.91	13.85	2.73	0.22	4.36	1.20
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	47.55	4.56	2.61	2.93	1.95	0.33	0.98	1.63	0.33	0.65
testis, adult, pool1	10026-101D8	49.07	3.65	3.33	0.97	1.18	0.75	0.21	1.07	0.54	1.50
testis, adult, pool2	10096-102C6	61.80	0.45	4.51	1.80	2.71	0.90	0.45	1.80	1.35	0.45
thalamus - adult, donor10196	10168-103B6	61.82	11.04	6.62	1.10	1.10	2.21	0.00	2.21	4.42	0.00
thalamus, adult, donor10252	10154-103A1	62.04	7.19	5.47	2.19	1.09	1.56	0.47	0.63	1.41	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	9.24	3.08	10.78	0.00	0.00	6.16	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	29.64	3.13	4.78	2.80	0.66	0.66	0.99	0.49	1.65	0.16
thalamus, newborn, donor10223	10366-105F6	35.09	1.73	6.90	3.45	0.58	2.88	3.45	0.58	3.45	0.58
throat, adult	10209-103G2	39.20	2.25	2.75	1.00	0.25	0.25	0.00	0.00	0.50	0.00
throat, fetal, donor1	10061-101H7	47.53	7.92	3.05	2.44	0.91	0.61	0.30	0.30	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	57.04	13.32	0.79	4.97	1.19	0.20	2.78	0.00	0.20	0.20
thymus, adult, pool1	10027-101D9	76.85	3.28	2.09	1.59	1.39	0.30	0.60	0.70	0.20	0.99
thymus, fetal, pool1	10043-101F7	74.71	4.16	3.74	1.35	1.77	0.52	1.14	0.31	0.62	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	34.30	4.65	0.66	2.13	1.20	0.40	0.93	0.53	0.40	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	31.71	5.59	1.26	1.26	1.12	0.14	1.54	0.56	0.00	0.14
thyroid, adult, pool1	10028-101E1	50.30	2.43	1.12	1.21	0.37	0.47	0.56	0.47	0.09	0.28
thyroid, fetal, donor1	10060-101H6	45.61	3.43	0.53	2.90	0.00	0.53	1.05	1.05	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	3.08	0.00	0.00	3.08	3.08	0.00	0.00	0.00	3.08
tongue, adult	10203-103F5	29.77	2.33	0.93	1.16	1.16	0.93	0.47	0.93	0.70	0.47
tongue, fetal, donor1	10059-101H5	34.29	3.55	1.97	1.18	0.00	0.39	0.79	0.00	0.79	0.79
tonsil, adult, pool1	10047-101G2	56.70	4.51	2.40	0.70	1.00	0.30	0.50	0.30	0.20	0.10
trachea, adult, pool1	10029-101E2	42.70	2.62	1.96	0.65	0.65	0.74	0.49	0.49	0.33	0.49
trachea, fetal, donor1	10058-101H4	30.78	3.46	0.38	1.54	0.00	0.38	0.77	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.13	3.54	0.35	1.77	0.71	0.71	0.71	0.71	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	55.42	4.66	6.48	2.84	1.11	2.23	0.81	0.51	0.51	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	43.56	6.74	9.87	3.29	1.72	1.72	1.41	0.47	0.78	0.63
tridermal teratoma cell line:HGRT	10694-109G1	11.42	1.90	9.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	34.37	3.72	3.39	1.78	1.02	0.59	0.76	0.17	1.10	0.00
umbilical cord, fetal, donor1	10057-101H3	45.90	8.35	2.09	2.09	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	53.75	4.44	2.39	1.88	0.34	0.17	1.02	0.34	0.51	0.34
uterus, fetal, donor1	10055-101H1	43.51	6.14	3.58	2.56	0.00	0.51	1.02	0.00	0.51	0.00
vagina, adult	10204-103F6	27.14	3.23	1.29	0.65	0.65	0.00	0.00	0.00	0.65	0.65
vein, adult	10191-103E2	40.99	2.85	1.53	0.88	0.00	1.10	1.10	0.66	0.00	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	26.70	3.74	0.53	1.07	0.80	0.27	0.27	0.27	0.00	0.00